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The situation of the inferior 
gentry, or Franklins, as they were 
called, who, by the law and spirit 
of the English constitution, were 
entitled to hold themselves 
independent of feudal tyranny, 
became now unusually precarious. 
Sir Walter Scott, Ivanhoe 
 
 
1.1 About this work 
The research of drug residues in farm animal tissues or fluids is one of the 
means by which the National Authorities watch over the healthy, hygienic and 
organoleptic properties of food of animal origin. However, some substances 
with doubtful effects, or with a urinary threshold level due to their natural origin, 
like some anabolic steroid hormones, or compounds that are allowed only if a 
proper medical cause justifies their use, e.g. corticosteroids, complicate the tasks 
of the Health Authorities. These compounds have been appropriately defined 
“grey-zone substances” by Wim Van Thuyne in its Ph.D. thesis about doping in 
sport (1) and described by Scart et al:“synthetically produced hormones that are 
also known to be endogenous under certain conditions, dubbed ‘pseudo-
endogenous’ or ‘grey zone substances’ due to their dual synthetic/endogenous 
nature” (2). 
The present work deals with the anabolic steroid boldenone, a pseudo 
endogenous substance with a close structural resemblance to testosterone, and 
with prednisolone and prednisone, which show the same resemblance 
respectively to cortisol and cortisone. 
From 2004, our research group is interested in the possibility that the presence 
of boldenone in farm animal biological fluids is not only due to an illicit 
administration but even as a “natural origin” substance. The first trial presented 
in this thesis regards the cattle, while the second one, carried out within a 
collaboration with UNIRELab, the Italian antidoping laboratory for equestrian 
sports, regards racing horses.  
Beginning from 2009, we began to study prednisolone and prednisone: the third 
and fourth trials are preliminary studies made with the aim to verify if the 
positivity to these two glucocorticosteroids could represent a matter of analogy 
with the observations made on boldenone.  
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1.2 Androgen steroids 
The major androgen hormone is testosterone, belonging to the family of steroid 
hormones, like glucocorticoids, mineral corticoids, estrogens, progestins and 
vitamin D. Its secretion in mammals, occurs in the testes of males but it is also 
synthesized in far smaller quantities in females by the thecal cells of the ovaries, 
by the placenta, as well as by the zona reticularis of the adrenal cortex in both 
sexes. In the testes, testosterone is produced by the Leydig cells (2). About 40%  
of  the blood testosterone is transported bound with high affinity to a specific 
plasma protein, sex hormone binding globulin (SHBG), while albumin binds it 
with low affinity, almost 60%, leaving it approximately 2% free. The latter two 
components are considered as "bioavailable" testosterone (4). Like other steroid 
hormones, testosterone is derived from cholesterol (Figure 1). The first step in 
the biosynthesis involves the cleavage of the side chain of cholesterol by 
CYP11A, a mitochondrial cytochrome P450 oxidase with the loss of six carbon 
atoms to give pregnenolone. In the next step, two additional carbon atoms are 
removed by the CYP17A enzyme in the endoplasmic reticulum to yield C19 
steroids. In addition, the 3-hydroxyl group is oxidized by 3-β-HSD (3-β-
hydroxisteroid dehydrogenase – not shown) to produce androstenedione. In the 
final and rate limiting step, the C-17 keto group androstenedione is reduced by 
17-β hydroxysteroid dehydrogenase to yield testosterone. 
 
1.2.1 The Hypothalamus-Hypophysary-Gonadal Axis 
The principal stimulus of testosterone secretion in men, comes from luteinizing 
hormone (LH), secreted by the pituitary gland, perhaps potentiated by follicle-
stimulating hormone (FSH), also secreted by hypophysis. The secretion of LH is 
positively regulated by hypothalamic gonadotropin-releasing hormone (GnRH), 
while a negative  feedback is exerted by  testosterone on LH secretion. The 
secretion of GnRH from the hypothalamus is in pulses, and results in a secretion 
of LH occurring approximately every 2 hours, and higher in the morning. 
Testosterone secretion is likewise pulsatile, too, and diurnal, with the highest 
plasma concentrations occurring at about 8 A.M. and the lowest at about 8 P.M. 
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Figure 1 - Illustration of the pathway of testicular testosterone synthesis. The uptake of cholesterol and 
its conversion to testosterone involves numerous receptors and enzymes, including ScarB1 (Scavenger 
receptor class B. member 1), which is responsible for HDL uptake into Leydig cells, StAR  
( Steroidogenic acute regulatory protein) that transport the cholesterol from the outer to the inner 
mitochondrial membrane and the steroid-converting enzymes P450scc and P450c17, which are 
involved in the conversion of cholesterol to testosterone. ( Figure and caption from Ref 5). 
 
In women, LH stimulates the corpus luteum (formed from the follicle after 
release of the ovum) to secrete testosterone. The principal inhibitors of LH 
secretion in women, however, are estradiol and progesterone, not testosterone 
(4)  
 
1.2.2  Main physiologic effects of androgen steroids 
The androgens bind to the androgen nuclear receptor NR3A, which possesses 
an amino-terminal domain, a DNA-binding domain, and a ligand-binding 
domain. Testosterone can act as an androgen either directly, or indirectly, after 
conversion catalyzed by a 5α-reductase, to dihydrotestosterone, which have 
higher affinity for the receptor. The androgen bound to the ligand-binding 
domain causes a conformational change in the receptor, the ligand-receptor 
complex can so translocate to the nucleus and via the DNA-binding domain, 
transcriptionally regulates the expression of androgen-responsive genes (6). 
12 
 
Androgen steroids effects can be classified as anabolic and androgenic, although 
many of these effects can be considered super imposable. Briefly:  
9 Anabolic effects include growth of muscle mass and strength, increased 
bone density and strength, and stimulation of linear growth and bone 
maturation. 
9 Androgenic effects include maturation of the sex organs, particularly the 
penis and the formation of the scrotum in the fetus, and at puberty the 
appearance of the male secondary sex characteristics. 
1.2.3 Metabolism of androgen steroids  
Androgen steroids undergo phase I and phase II reactions, that transform them 
into less toxic, less active, and/or more polar forms. Phase-I reactions modify 
the parent compound via hydrolysis, oxidation, and/or reduction (7, 8). As an 
example, it can be cited the non-reversible reduction of the C-4,5 double bond 
of 4-ene-3-one ring A which leads to the formation of two isomers, in a ratio 
depending on the relative catalyzing effects of 5α- and 5β-reductase enzymes (9) 
and the subsequent reduction of the 3-keto group, predominantly by 3α-
hydroxysteroid dehydrogenase (3HSD). In D-ring, 17β-hydroxysteroid 
dehydrogenase (17HSD) can form 17-keto metabolites (Figure 2). Although 
phase-I reactions already increase the polarity and the excretion of AAS, these 
modifications are most often preparative stages for reactions that expose reactive 
sites of the analyte structure for the following phase-II, i.e. conjugation 
reactions. For androgen steroids, the main phase-II reactions are glucuronidation 
and sulfation. These conjugations occur mainly in the liver, but also in the 
intestinal mucosa, usually reduce the steroid activity and get him ready to the 
secretion with urine or bile (10).   
1.2.4 Androgen steroids and farm animals 
In observance to the Council Directive 96/22/EC of 29 April 1996 (concerning 
the prohibition on the use in stockfarming of certain substances having a 
hormonal or thyrostatic action and of ß-agonists), the Council Directive 
96/23/EC of 29 April 1996 (on measures to monitor certain substances and 
residues thereof in live animals and animal products) includes androgen steroids 
in Group A, that contains substances prohibited or firmly restricted for use in 
food producing animals, and specifically in category A3 - steroids. Nevertheless, 
the Council Directive 96/22/EC, in article 4, states:” (...) the Member States may 
authorize: 1. the administering to farm animals, for therapeutic purposes, of 
oestradiol 17 α, testosterone and progesterone and derivatives which readily yield  
13 
 
 
 
Figure 2. Enzymes involved in some androgen steroid phase-I reactions.  
 
the parent compound on hydrolysis after absorption at the site of application. 
Veterinary medicinal products used for therapeutic treatment must comply with 
the requirements for placing on the market laid down in Directive 81/851/EEC 
and be administered only by a veterinarian, by injection or for the treatment of 
ovarian dysfunction in the form of vaginal spirals, but not by implant, to farm 
animals which have been clearly identified. Treatment of identified animals must 
be registered by the veterinarian responsible. The latter must record at least the 
following details in a register, which may be the one provided for in Directive 
81/851/EEC: type of treatment, the type of products authorized, the date of 
treatment, the identity of the animals treated. The register must be made 
available to the competent authority at its request (..)”. 
In other countries, like USA, Canada, Australia and New Zealand, the 
administration of testosterone and the synthetic compound trenbolone is 
allowed in food producing animals.   
The illicit use of anabolic steroids in the European Union probably met a great 
improvement in the ’80s and ’90s, decreasing at the end of the 90s, when the 
non-compliances were about 0.1% in bovines and 0.3% in swine. In Italy, only 
boldenone was found in the last years (11), but it is unclear whether the origin of 
its presence in urine is natural or due to an illicit treatment. This aspect of the 
question is later on discussed.  
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1.3 Glucocorticosteroids 
1.3.1 A short premise 
 In the 1930s, Edward Kendall of the Mayo Foundation in Rochester (MN, 
USA) isolated six hormones from the adrenal glands. He named them in the 
order in which they were isolated: compounds A through F. In the same years, 
Philip Hench, also at the Mayo Foundation, had observed that patients who had 
rheumatoid arthritis were sometimes relieved if they developed jaundice, during 
pregnancy, and immediately after unrelated surgery . He hypothesized the 
secretion of a natural anti-rheumatic, that he termed "Substance X". The two 
physicians conferred some times and agreed about the possibility that the adrenal 
hormones might help in treating rheumatoid arthritis and that "Substance X” 
could be a steroid. In January 1941, Philip Hench wrote in his notebook: "Try 
Compound E in rheumatoid arthritis". The anti-inflammatory effect of the 
compound, cortisone, was so discovered. 
Contemporary, in the University of Basel, Tadeus Reichstein isolated and 
explained the constitution of aldosterone, a hormone of the adrenal cortex, 
which until then had not been isolated. Reichstein also collaborated with E. 
Kendall and P. Hench in their work on the hormones of the adrenal cortex 
which culminated in the isolation of cortisone and the discovery of its 
therapeutic value in the treatment of rheumatoid arthritis. 
It was then found that many other diseases of an inflammatory nature were 
relieved by cortisone. Although it was found later that cortisone, like insulin, is a 
symptomatic drug, i.e. acts only so long as it is given to the patient, and that it 
does not cure the disease, the discovery of the activity of cortisone was a great 
step forward. It has led to our modern knowledge of the hormones of the 
adrenal cortex and their uses in medicine. 
In 1950 they were awarded of the Nobel prize “For their discoveries relating to 
the hormones of the adrenal cortex, their structure and biological effects” 
(12,13) . 
 
In 1955, a Research Group of Schering Corporation from Bloomfield (NJ, 
USA) described the “clinical effectiveness of two new, potent antiarthritic 
steroids, metacortandracin (Meticorten) and metacortandralone (Meticortelone)” 
The structures of these compounds were Δ1,4-pregnadiene-17α, 21-, diol-3 11, 20 
trione and Δ1,4-pregnadiene-11β 17α, 21-triol-3, 20 dione. Their present names 
are prednisone and prednisolone, respectively. The adrenocortical activity of 
these two steroids was measured and resulted 3 to 4 times the activity of 
cortisone or cortisol (14). 
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In the same year Nobile and co-workers reported that the oxidation of the latter 
two corticosteroids by Corynebacterium simplex can be used to prepare their Δ1 
dehydrogenated analogues (15, 16). 
 
The microbiological introduction of the double bond in position 1,2-(Δ1) of the 
steroid structure is still used for the production of prednisone and prednisolone, 
as the chemical route is inferior in both product purity and yield (17, 18). 
 
1.3.2 Adrenal steroids 
The surrenal glands, or adrenals, are endocrine glands located atop the kidneys 
and are constituted by an outer part - the cortex - and an inner part - the 
medulla. The cortex contains three zones: zona glomerulosa, fasciculata and 
reticularis. In these zones three main types of hormone are produced. They are, 
respectively: mineralocorticoids (aldosterone, deoxycorticosterone) that regulate 
hydro saline equilibrium, glucocorticoids (cortisol, corticosterone), active on 
metabolism, in stress and in the inflammatory processes, and precursors 
(dehydroepiandrosterone [DHEA] and androstenedione) of androgen steroids. 
Cholesterol is the precursor for all adrenal steroids and it is principally provided 
in its free form following hydrolysis, in adrenal tissue, of the circulating low-
density lipoprotein (LDL) cholesterol (19). Cholesterol also can be generated de  
 
 
 
Fig. 3. Steroidogenesis in the adrenal cortex; CYP17: steroid 17-hydoxylase; CYP11B2: aldosterone 
syntase; CYP11B1: steroid11-hydoxylase; Ang II: angiotensin II. The figure is a combination of two 
figures in Ref. 4 and 25. 
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novo within the adrenal cortex from acetyl coenzyme A (20), and there is 
evidence that the adrenal can use high-density lipoprotein (HDL) cholesterol 
(21). 
In the medulla, catecholamines (adrenaline, noradrenaline,, and dopamine) are 
produced. 
The biochemical pathways involved in adrenal steroidogenesis are shown in 
Figure 3(4, 25). 
 
1.3.3 The Hypothalamus-Hypophysary-Adrenal Axis 
The adrenal cortex is stimulated by the adrenocorticotropic hormone (ACTH, 
also called corticotropin), secreted from the anterior pituitary  in response to  
 
 
Figure 4. Hypothalamus-hypophysary-adrenal axis. (HPA) 
 
corticotropin-releasing hormone (CRH) from the hypothalamus.  The  
cooperation, of the three glands, considered as a single system, is named 
hypothalamus-hypophysary-adrenal axis (HPA) (figure 4). Bovine ACTH is a 39 
aminoacids peptide (26) (Figure 5) whose biological activity is closely related to 
the structure of NH2 terminus.  More specifically, it stimulates secretion of 
glucocorticoids such as cortisol; aldosterone, the other major steroid hormone 
from the adrenal cortex is under control of the peptide Angiotensin II, 
potassium and, only to a lesser extent, ACTH.  
STRESSOR 
HYPOTALAMIC  
          CRH
HYPOPHYSARY 
         ACTH 
CORTISOL
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The secretion of adrenal androgen steroids is likely stimulated by ACTH, too. In 
women, more than 50% of active androgens are generated by peripheral 
conversion from DHEA. In men, this contribution is much smaller because of 
the testicular production of androgens (27). This stimulation may explain why 
DHEA and androstenedione demonstrate a similar diurnal rhythm to cortisol. 
(25). This rhythm is entrained by higher neuronal centers in response to sleep-
wake cycles, such that levels of ACTH peak in the early morning hours, causing 
the circulating glucocorticoid levels to peak at approximately 8 A.M. (4).  
 
Figure 5. Structure of bovine ACTH. 
 
Any physical or mental stress can raise cortisol concentrations in blood due to 
enhanced secretion of CRH in the hypothalamus. This can make very difficult to 
measure blood levels of cortisol, especially in animals (28). Moreover, a high 
blood level of cortisol inhibits the release of CRH and ACTH, so making a 
negative feedback loop (29) (Figure 4).  
 
1.3.4 Main physiologic effects of glucocorticoids  
Glucocorticoids exert their actions through the interaction with the 
glucocorticoid receptor (GR), a member of the nuclear hormone receptor 
superfamily; once activated by glucocorticoids, GR translocates from the cytosol 
of target cells to the nucleus, and binds to specific glucocorticoid response 
elements within the regulatory DNA sequences and, finally, transcriptionally 
regulates the expression of GC-responsive genes (22-24). 
The term glucocorticoid indicates that the early observations about these 
corticosteroids involved the glucose metabolism; cortisol indeed stimulates 
several processes that serve to increase and maintain normal glucose 
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concentrations in blood through an action on glycogen, protein and lipid 
metabolism (25). These effects can be so schematized:  
 Liver  
9 Cortisol stimulates glycogen deposition by increasing glycogen 
syntase and inhibiting glycogen phosphorilase, that mobilizes it. 
9 Glucose output increases by activating enzymes involved in 
gluconeogenesis, mainly glucose-6-phosphatase and 
phophoenolpyruvate kinase.  This pathway results in the synthesis 
of glucose from non-hexose substrates such as amino acids and 
lipids. 
 Other tissues (Adipose tissue and muscle) 
9 Glucose uptake and use is inhibited.  
9  Lipolysis in adipose tissue is activated, resulting in a raise of free 
fatty acids and tryglicerides into the circulation; also total 
cholesterol increases even if HDL cholesterol falls.  
9 Fatty acids released by lipolysis are used in tissues like muscle 
through their conversion into Acetyl-CoA for production of 
energy stored as ATP, 
9 The released glycerol provides another substrate for 
gluconeogenesis. 
 
The other major effect of glucocorticoids is constituted by the suppression of 
the immune system and by the anti-inflammatory actions. 
 Immune system 
9 The lymphocyte counts acutely reduce in peripheral blood because 
of the redistribution to spleen, lymph nodes and bone marrow 
(30), and stimulation of apoptosis. Neutrophyl counts increase, 
eosinophils fall (an effect hystorically used to evaluate 
corticosteroid activity) (31). 
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 anti-inflammatory actions 
9  Glucocorticosteroids impair prostaglandin synthesis through the 
induction of lipocortins, a group of peptides that inhibit 
phospholipase A2 activity on arachidonic acid: the production of 
the mediators of inflammation prostaglandins and leucotriens, is 
thus inhibited. Minor anti-inflammatory effects involve inhibitory 
actions on macrophagae and prevention of histamine activators 
(25). 
Finally, it can be stated the physiologic effects of these steroid hormones are a 
huge number: likely, no cell lacks steroid receptors. At all events the best known 
and studied effects of glucocorticoids are on carbohydrate metabolism, immune 
function and inflammation.  
1.3.5  Glucocorticoid metabolism  
Only about 10% of circulating cortisol is free, the remaining bound to cortisol-
binding globulin (CBG) also named transcortin. The excretion of free cortisol 
through the kidneys represents only 1% of total secretion rate.  
In man, the major routes of cortisol metabolism are the interconversion of 
cortisol (Kendall’s compound F) to cortisone (compound E) through the activity 
of 11β-hydroxysteroid dehydrogenases or reduction of the C4-5 double bond by 
either 5β-reductase or 5α-reductase to yield respectively 5β-tetrahydrocortisol 
(THF) or 5α-THF (allo-THF). THF, allo-THF and tetrahydrocortisone (THE) 
are conjugated rapidly with glucuronic acid and excreted in the urine. 
Downstream, cleavage of THF and THE to the C19 steroids 11-hydroxy or 11-
oxo-androsterone or etiocholanolone can occur. Alternatively, reduction of the 
20-oxo group by 20 α- or 20 β -hydroxysteroid dehydrogenase yields α and β 
cortols and cortolones, respectively, with subsequent oxidation at the C21 
position to form the extremely polar metabolites, cortolic, and cortolonic acids. 
Hydroxylation at C6 to form 6 β-hydroxycortisol is described, as is reduction of 
the C20 position, which may occur without A ring reduction giving rise to 20 α-
and 20 β-hydroxycortisol. 
Approximately 50% of secreted cortisol appears in the urine as THF, allo-THF, 
and THE; 25% appears as cortols/cortolones. Ten percent appears as C19 
steroids, and 10% appears as cortolic/cortolonic acids. The remaining 
metabolites are free, unconjugated steroids (cortisol, cortisone, and 6 β- and 20 
α/20 β-metabolites of F and E) (Figure 6) (25). 
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Figure 6. Major pathways of cortisol metabolism. Conversion of cortisone to cortisol is catalyzed by 
11β-hydroxysteroid dehydrogenase 1, the reverse by 11β-HSD hydroxysteroid dehydrogenase 2. 
Tetrahydro metabolites are produced by the actions of 5α or 5β-reductase (A ring reduction) and 3β-
hydroxysteroid dehydrogenase (3keto- to 3 hydroxy- group). Figure modified from Ref. 25.  
 
The chemical structures of cortisol and of its metabolites are represented in 
Figure 7. 
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Figure 7. Chemical structures of cortisol and its major metabolites 
1.3.6 Studies on glucocorticoid metabolism in farm animals 
 Few data are available in literature about the metabolism of glucocorticoid in 
farm animals and are mainly addressed to animal wellbeing, with the aim to 
evaluate the effects of stress (e.g. transport, novel environment, machine 
milking) on the release of cortisol and excretion of its metabolites through 
biological fluids like urine, faeces or saliva, different from blood. It is indeed 
evident that blood sampling can itself cause stress, even if catheterization is 
made.  
In a paper regarding the possibility of using saliva in dairy cattle, J. A. Negrão et 
al. noticed that corticosteroid concentrations in saliva are directly related to those 
in plasma in humans, dogs, pigs, and domestic ruminants for several Authors, 
while other ones observed limitations in this relationship. In their work, they 
concluded that a positive correlation between salivary and plasmatic cortisol 
concentrations in both calves and adult cattle exists even though they did not 
consider saliva sampling a stress-free method of sampling, due to restraining 
operations, particularly in adult cows(32). 
After intravenous infusion of 14C-cortisol in one ewe, Lindner (33) in 1972 
found two thirds of the radioactivity in the bile; the predominant radioactive 
metabolite were tetrahydrocortisol, tetrahydrocortisone and cortolones, but 
C19O3 steroids formed, too. Only the 40% of the dose administered was voided 
in the faeces and the enterohepatic circulation was demonstrated.  
In 1996, Palme et al (34) recorded the radioactivity in sheep faeces and urine 
after infusion of 14C-cortisol: they found 28% of radioactivity in faeces, with a 
peak concentration about 12-13 hours after infusion. 
Palme and Möstl (35) demonstrated  that the sheep faecal metabolites are free 
steroids and that a large amount is represented by 11, 17 dioxoandrostanes 
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(11,17.DOAs) In this work they developed an immunoassay for detecting 
glucocorticoid, the 11,17.DOA test, specifically for use in ruminants but useful 
in a variety of species including sheep, cattle, horses, roe deer, hares, okapi, 
Barbary macaque, and red deer The antibody (raised in rabbit against 11-
oxoetiocholanolone-3-HS:BSA) cross-reacts with 11,17-dioxoandrogens  
(84-100% 5α-androstanes; 5–15% 5β-androstanes).  
The 11,17 DOAs increase in cow faeces (36) after a two hours road transport. 
Similar results are described by Morrow et al (37), who conducted an experiment 
on Holstein dairy cows to detect corticosteroids metabolites in faecal samples. 
When the cows were exposed to a new housing environment, the concentrations 
of glucocorticoid metabolites peaked two days after the move (from 151 to 
352%).  
In 2002, Antignac et al. (38) performed a study about corticosteroid phase II 
metabolites in bovine urine. The urine of two cows, “Normande” specie, 
weighing 400–500 kg, were analyzed for cortisol and tetrahydrocortisol (free, 
sulfate and glucuronide) before an intramuscular injection of 40 mg of 
dexamethasone acetate (Animal 1) or dexamethasone phosphate (Animal 2) and 
for dexamethasone (free, sulfate and glucuronide) one day after the treatment. 
(Figure 8).  
Not considering the data on dexamethasone, an exogenous, fluorinated 
corticosteroid, the difference between the total proportion of conjugated forms 
of tetrahydrocortisol (40–65%) and cortisol (2–8%) is strong. The high amount 
of tetrahydrocortisol glucuronide is explained by the Authors with the reduction 
of keto-group to hydroxil in position 3 of the A ring of tetrahydrocortisol, that 
probably favors the conjugation reactions. 
 
1.3.7 Veterinary uses of glucocorticoids in farm animals 
The common used glucocorticoids in veterinary medicine are prednisolone, 
prednisone, metylprednisolone, betamethasone, dexamethasone, triamcinolone 
acetonide, flumethasone (39) (Table 1). In bovine, swine, ovine and caprine 
prednisolone, betamethasone and dexamethasone can be used, via IM or IV, in 
the anti-inflammatory (particularly involving locomotor and cutaneous 
apparatuses) and antiallergic symptomatic therapies; in pregnancy-related 
pathologies (gravidic toxicosis, ketosis) in case of metabolic disorders, shock and 
intoxications; topically prednisolone is used for conjunctivitis, 
blepharoconjunctivitis, keratoconjunctivitis and inflammations at the back of the 
eye and, by intramammary infusion, for the treatment of bovine mastitis. 
Betamethasone is also used for the induction of parturition in cows (40). The 
horse respiratory tract acute inflammation is treated with prednisolone both oral 
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and IV or IM, while oral administrations of dexamethasone and triamcinolone 
are preferred for the lung chronic inflammation (41).  
 
Fig. 8 Relative proportions (%) of free, glucuronide, and sulfate forms for endogenous cortisol, 
tetrahydrocortisol, and exogenous dexamethasone in bovine urine samples of two animals treated with 
40 mg of dexamethasone acetate (Animal 1) and dexamethasone phosphate (Animal 2) (Figure and 
caption entirely drawn on Ref. 33). 
 
 
Table 1. Relative potencies and biological half-lifes of commonly used corticosteroid 
1.3.8 Possible illicit uses of glucocorticoids  
French bicycle enthusiasts turned up their noses in 1999 when the Yellow Jersey 
Lance Armstrong  was found positive to minimal residues of corticosteroids in 
 
Compound Relative 
Glucocorticoid 
Activity 
Biological 
Half-life (hr) 
Cortisol 1 8-12 
Cortisone 0.8 8-12 
Prednisone 5 12-36 
Prednisolone 5 12-36 
Methylprednisolone 5 12-36 
Triamcinolone >5 24-48 
Dexamethasone 25 36-72 
Betamethasone 25 36-72 
 
25 
 
urine. Its defense was that he used an ointment to treat a severe dermatitis, and 
he had a full discharge. More recently, the CONI (Italian Olympic Committee) 
disqualified for two months the Turin Juventus Football Club doctors for a 
mistake in transmitting the declaration of systemic use of corticosteroids of the 
football player Fabio Cannavaro, who was sting by a wasp and found positive to 
these substances in October 2009.  
Indeed, the World Anti Doping Agency (WADA) prohibits oral, intravenous, 
intramuscular or rectal uses of glucocorticosteroids, requires a declaration of Use 
for intraarticular, periarticular, peritendinous, epidural, intradermaland inhalatory 
administrations, and does not require any declaration when topical preparation 
are used (auricular, buccal, dermatological, gingival, nasal, ophthalmic and 
perianal disorders) (42). 
 
In zootechnics, synthetic corticosteroids may have an illicit use as growth-
promoters either alone or with other active principles (i.e., steroid hormones 
and/or β-agonists), in order to take advantage of their synergistic effects with 
different illegal growth-promoting agents. In particular, dexamethasone can 
reverse the β2-agonist-mediated down-regulation of β2-receptors, so enhancing 
the repartitioning effects of β2-agonists. In addition, the glucocorticoid-mediated 
electrolyte imbalance results in polydipsia and polyuria, which may decrease the 
concentration of other illegal substances in the urine (43). 
Low doses of corticosteroids raise the food intake, the weight of the animal and 
the water retention, but reduce the food conversion index, and the proteic and 
lipidic anabolism. Prolonged administrations or high doses of corticosteroids can 
induce muscle atrophy because of the enhanced proteic catabolism that causes a 
decrease of animal grow rate (44).  
The above mentioned electrolyte imbalance, that consists into sodium retention, 
potassium and calcium elimination, tubular reabsorption of chlorine and sodium, 
results in a raise of extracellular liquid volume: a treatment in the last 30-40 days 
before the slaughter increases the carcass weight, but also decreases meat quality 
and commercial value. After the slaughter indeed, the altered ability of the meat 
to retain water, makes the carcass abnormally drip. This illicit treatment is 
generally made as a replacement of the administration of anabolic steroids, some 
weeks before the slaughter, to avoid their detection by health authorities and the 
weight loss due to interruption of anabolic steroid administration (45). 
 
1.3.9 Legal aspects 
In the European Union, the use of corticosteroids in livestock is indicated for 
therapeutic reasons only and is regulated by the Commission Regulation (EU) 
No 37/2010 of 22 December 2009 on pharmacologically active substances and 
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their classification regarding maximum residue limits in foodstuffs of animal 
origin. MRLs (maximum residue limits) for betamethasone in cattle and pigs, 
dexamethasone in cattle, pigs, horses and goats; methylprednisolone and 
prednisolone for cattle are indicated in the Annex  and reported in table 2. 
From 1988, the Italian National Residue Program (PNR) provides for the 
surveillance and the monitoring of residues of chemical substances in foods with 
animal origin. Until 2006 the PNR was the expression of the Legislative Decree 
336 of the 4th of August 1999, that followed the indications of the Council 
Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in 
stockfarming of certain substances having a hormonal or thyrostatic action and 
of ß-agonists and the Council Directive 96/23/EC of 29 April 1996 on measures 
to monitor certain substances and residues thereof in live animals and animal 
products. Today, the PNR is the expression of the Legislative Decree 158 of the 
16th of March 2006, that acknowledges the Directive 2003/74/EC, amending 
Council Directive 96/22/EC and concerning the prohibition on the use in 
stockfarming of certain substances having a hormonal or thyrostatic action and 
of β-agonists.  
Two categories of residues are envisaged: the “A” category includes products 
with an anabolic effect and substances forbidden in cattle intended for 
consumption and so employed fraudfully to improve the animals performances; 
The “B” category comprehends three families of substances. The first two ones 
regard veterinary drugs allowed in cattle treatment, with defined MRLs. The 
third family is made up of environmental contaminants as the organic 
chlorinated compounds, heavy metals and substances that may be absorbed by 
environment and enter in food chain. 
The analyses for the research of residues must be carried out using validated 
methods according to Commission Decision 2002/657/EC concerning the 
performance of analytical methods and the interpretation of results. Moreover 
the sampling procedures are reported in the Commission Decision 98/179/EC 
laying down detailed rules on official sampling for the monitoring of certain 
substances and residues thereof in live animals and animal products. 
Different institutions cooperate to the organization and the execution of the 
PNR.  
At a national level or, in other words, in the Ministry of Health, the General 
Direction of Veterinary Health and Foods coordinates all the activities 
concerning the fulfillment of the Project and represents the competent 
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Pharmacologically active 
substance  
and marker residue 
Animal 
species MRLs Target tissue 
Betamethasone 
Bovine 
0.75 µg/kg Muscle 
2.0 µg/kg Liver 
0.75 µg/kg Kidney 
0.3 µg/kg Milk 
Porcine 
0.75 µg/kg Muscle 
2.0 µg/kg Liver 
0.75 µg/kg Kidney 
Dexamethasone 
Bovine 
0.75 µg/kg Muscle 
2.0 µg/kg Liver 
0.75 µg/kg Kidney 
0.3 µg/kg Milk 
Porcine 
0.75 µg/kg Muscle 
2.0 µg/kg Liver 
0.75 µg/kg Kidney 
Equidae 
0.75 µg/kg Muscle 
2.0 µg/kg Liver 
0.75 µg/kg Kidney 
Caprine 
0.75 µg/kg Muscle 
2.0 µg/kg Liver 
0.75 µg/kg Kidney 
0.3 µg/kg Milk 
Methylprednisolone Bovine 
10 µg/kg Muscle 
10 µg/kg Fat 
10 µg/kg Liver 
10 µg/kg Kidney 
Prednisolone Bovine 
4 µg/kg Muscle 
4 µg/kg Fat 
10 µg/kg Liver 
10 µg/kg Kidney 
6 µg/kg Milk 
Table 2. MRLs of Betamethasone, Dexamethasone, Methylprednisolone and Prednisolone, as 
indicated by the Commission Regulation (EU) No 37/2010. 
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administrative Authority towards European Union, while the Health Superior 
Institute (Istituto Superiore di Sanità) coordinates the technical scientific aspects, 
as Reference National Laboratory for residues. 
On a regional scale, the Regional Residues Program (PRR) is defined according 
to the characteristics of the different areas, the extent of the zoo technical 
property, the number of slaughters, the handlings of drugs and feedstuffs; this 
project is sent out to territorial veterinary services that define the method of 
implementation of samples. The regional Councils, through the veterinary 
services coordinate of the activity, collect obtained data send them to the 
Ministry of Health every six month. 
The samplings are made both in breedings (primary production) and in first 
transformation factories, like slaughterhouses or milk collection centres. 
The samples are analyzed in Experimental Zooprophylactic Institutes 
laboratories (Istituti Zooprofilattici Sperimentali). On the basis of the analytical 
results, if banned substances residues are found or the content of residues of 
authorized substances or environmental contaminants exceed the fixed limits, 
administrative as well as criminal sanctions are provided, if a risk for public 
health is set (Article 40 of the code of criminal procedure about the adulteration 
of foodstuff). 
Finally, the Ministry of Health yearly passes all the data to the European 
Commission , together with the new year planning. 
 
After briefly outlining the legal aspects regarding the residues in farm animals, 
some considerations have to be done about the glucocorticoids. Indeed, they 
may be considered under two aspects: the Commission Regulation (EU) No 
37/2010, in Annex sets the MRLs of dexamethasone, betamethasone, 
metylprednisolone and prednisolone. These substances are therefore considered 
legal drugs and their use is permitted in farm animals, if the suspension times are 
observed, so that the maximum concentrations in edible tissues are not 
exceeded. In the  Italian PNR they are categorized in class A3, i.e. substances 
having an anabolic effect and unauthorized substances/steroids, unless a 
therapeutic use has been declared in advance by the farm veterinary surgeon. 
This could cause a misuse of glucocorticosteroids, illicitly used as above 
described, but legally declared as therapeutic agents. 
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 1.3.10 Glucocorticoid residues in food of animal origin 
The determinations of betamethasone, dexamethasone, methylprednisolone and 
prednisolone MRLs are made on evaluations performed by the European 
Medicines Agency (EMEA) on the basis of pharmacological uses of these 
corticosteroids, that are indeed active principles of several human medicines. 
The indications include rheumatoid arthritis, severe hypersensitivity reactions, 
Crohn’s disease, haemolytic anaemia, leukaemias , malignant lymphoma and their 
administrations can be oral, intravenous or intramuscular. The preparations are 
generally well tolerated but adverse effects are known and include acute adrenal 
insufficiency and indications of glucocorticoid overactivity such as round face 
and wasted limbs. Growth retardation may occur in children, and resistance to 
infection is decreased due to suppression of the immune system. No one of the 
four glucocorticosteroids is considered mutagenic, carcinogenetic or genotoxic. 
Betamethasone and dexamethasone are contraindicated during pregnancy due to 
the risk to the foetus of cleft palate and intrauterine growth retardation. To 
confirm these contraindications the betamethasone NOEL for teratogenicity in 
rats is reported to be 0.4 mg/kg bw/day, while two studies on teratogenicity and 
foetotoxicity in rabbit with inadequate group sizes show a value of NOEL of 
0.003 mg/kg bw/day and the NOEL for dexamethasone embryotoxicity in rat 
produces a value of 0.01 mg/kg bw/day. 
The normal oral dose ranges from 0.5 mg/day (maintenance dose) to 5 mg/day 
(attack dose) for bethametasone, from 4 to 96 mg/person for 
methylprednisolone, and from 5 to 150 mg/person for prednisolone.  
The No Observed Effect Levels (NOELs) for all this corticosteroids are 
calculated regarding the increase in tyrosine aminotransferase activity in rat liver 
at oral doses, an indicator related to reduced growth and to the activation of 
gluconeogenic mechanisms in which lipids and amino acids, rather than 
carbohydrates, are used for energy production (46): 
The NOEL of bethametasone is 0.004 mg/kg bw, a value that could lead to an 
Acceptable Daily Intake (ADI) of 0.00004 mg/kg bw/day. Betamethasone, 
however, is the 16β-epimer of dexamethasone, whose 16-methyl group is above 
the plane of the steroid moiety, i.e in α-position. Because the similar 
toxicological properties and glucocorticoid activities of this two corticosteroids 
parallel, the EMEA adopted the lower dexamethasone ADI value, 0.000015 
mg/kg bw (0.0009mg/person). 
Methylprednisolone NOEL, is 0.016 mg/kg bw/day, and leads to an ADI of 
0.00016 mg/kg bw (i.e. 0.0096mg/person). 
Prednisolone has an ADI of 0.0002 mg/kg bw (i.e. 0.012 mg/person) calculated 
by applying a safety factor of 100 to the NOEL of 20 μg/kg bw/day.  
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Based on MRLs reported in Table 2, the daily intakes would be 52% and 99% 
for methylprednisolone and prednisolone respectively, while the theoretical 
estimated consumer intake of dexamethasone and bethametasone were 
0.0009125 mg/day, exceeding the ADI value of 0.0009 mg/day. The 
consideration of EMEA is that this would not represent a risk to human health 
because the substance is used only occasionally in individual animals (47-50). 
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Never buy bread from a butcher 
Irish wisdom 
 
2.1 Why Boldenone and Prednisolone? 
 
Boldenone is a steroid occurring in the two isomeric forms 17α-boldenone and 
17 β-boldenone. The latter one is commonly named boldenone. Boldenone 
possesses androgenic activity and differs from 17-β testosterone (testosterone) 
by only one double bond at the Δ1-2 position on ring A. European Directive 
96/22/EC amended by Directive 2003/74/EC and 96/23/EC bans  
β boldenone, a class A3 substance (growth promoter steroid), in products of 
animal origin and in livestock. Nevertheless, there is evidence that boldenone 
may arise naturally in bovine urine, probably following a contamination with 
microorganisms both of faecal or environmental origin. In chapter 3, a 
contribution to the comprehension of the mechanisms leading to the presence 
of boldenone in faeces contaminated urine was given, while the following work 
regards the transformation of phase II metabolites of androgenic steroids in 
urine of race horses. This work, besides shows that the problem regarding 
boldenone presence in urine regards the controls both in farm and in sport 
animals. 
 
Prednisolone (Δ1,4-pregnadiene-11β,17α,21-triol-3,20-dione) is a corticosteroid 
with gluconeogenetic and antinflammatory activities. Its structure is very similar 
to the cortisol one and differs from the hormone by only one double bond at the 
Δ1-2 position on ring A: a close analogy with boldenone and testosterone. 
Prednisolone is considered a synthetic corticosteroids; in the last years, 
nevertheless, this certainty began to waver in the mind of some italian 
researchers. The exceptional percentage in prednisolone positive bovine urine 
sampled at the slaughterhouse, compared to the absence of this steroid in urine 
sampled at the farm in Lombardy, led us to cover the route already made for the 
boldenone problem, (i.e. the contamination of urine, chapters 5 –faecal- and 6-
environmental) but particularly to study the effect of stress on a possible natural 
production of prednisolone by bovine organism, chapter 7). 
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In the midst was seen 
A lady of a more majestic mien, 
By stature and by beauty mark’d their sovereign Queen. 
And as in beauty she surpass’d the choir, 
So nobler than the rest was her attire; 
A crown of ruddy gold enclosed her brow, 
Plain without pomp, and rich without a show; 
A branch of Agnus Castus in her hand, 
She bore aloft her symbol of command.  
Geoffrey Chaucher, The Flower and the Leaf 
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3.1 Abstract 
It is established that bovine urine can result positive for boldenone and 
androstadienedione in consequence of faecal contamination. The simple transfer 
of steroids to urine is one minor aspect of faecal contamination. A high de novo 
production of steroids in faeces after deposition and in faeces-contaminated 
urine is almost certainly due to microbial activity, although the precursor 
compounds and transformations leading to the presence of these illegal steroids 
are unclear. We developed a simple in vitro method – incubation of faecal matter 
suspended in 0.9% saline – to induce steroid transformations in faeces, and 
analyzed the products by liquid chromatography/tandem mass spectrometry, 
without the need for prior extraction. Norethandrolone was the internal 
standard. The linearity (R2: 0.987–0.999), sensitivity (LODs: 0.3 to 1.0 ng/mL; 
LOQs: 1.0 to 3.0 ng/mL), precision (intra −day CVs: 2.6–8.2; inter-day CVs: 
4.5–11.5) and accuracy (percentage recovery: 89–120%) were calculated for the 
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studied steroids. Androstenedione, androstadienedione,   α−and   β−boldenone, 
testosterone and epitestosterone transformations were investigated. Mutual 
interconversion of steroids was observed, although 17  β−hydroxy steroids had 
low stability compared with 17  α−hydroxy and 17-keto steroids. The results 
suggest that this simple in vitro system may be an effective way of studying 
hormone transformations in faeces and, after analogue studies, in faeces-
contaminated urine. Copyright # 2007 John Wiley & Sons, Ltd.  
 
3.2 Introduction 
European Directive 96/22/EC bans  β−boldenone (17β hydroxyandrosta- 1,4-
dien-3-one; β−BOL), a class A3 substance (growth promoter steroid), in 
products of animal origin and in livestock. Urine analysis is currently used in the 
European Union (EU) to detect the illicit use of anabolic steroids including 
boldenone in cattle. Nevertheless, there is evidence that boldenone may arise 
naturally in urine (1). In 1996, Arts et al. (2) reported  α−boldenone (17 
 α−hydroxyandrosta- 1,4-dien-3-one;  α−BOL) up to 2.7 ng/mL, and  β−BOL 
up to 0.1 ng/mL, in the urine of untreated calves. More recently, Nielen et al. (3) 
reported  α−BOL,  β−BOL and also androstadienedione (1,4-androstadiene-
3,17-dione; ADD) in the dried faeces of untreated cattle at much higher levels 
than in the urine of animals administered  β−BOL undecylenate by 
intramuscular (IM) injection. De Brabander et al. (1) reported  α−BOL (1–10 
ng/g) and  β−BOL (0.1–2.0 ng/g) in faecal scrapings from calf skin, and 
Sangiorgi et al. (4) detected these substances in rectal faeces from untreated 
calves. We have shown that contamination of calf urine with faeces can render 
the urine positive for  α−BOL and occasionally for  β−BOL (5,6), and that 
considerable quantities of ADD, androstenedione (4-androstene-3,17-dione; 
AED) and  α−BOL can be produced in faeces after emission (6). The European 
Union Community Reference Laboratory for Residues (RIVM) have shown that 
faecal contamination of urine can be a source of false positivity for 
unconjugated  α−BOL (7). In the study, carried out on 261 veal calf urine 
samples suspected to contain α/β−BOL, coprostanol was used as marker of 
faecal contamination. It was not excluded that also unconjugated  β−BOL 
and  α−BOL-glucuronide could be endogenous or have originated from small 
amounts of faeces ingested by the animals. Furthermore, 28 samples containing 
more than 2 ng/mL of  α−BOL-glucuronide were tested for the presence of 6 
 β−hydroxy-17 α−boldenone and 6 β−hydroxy-17  β−boldenone, marker 
metabolites only found after administration of  β−BOL (8). The absence of this 
metabolite was considered a proof that  α−BOL-glucuronide and 
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unconjugated  β−BOL are no indicators for boldenone abuse.  β−BOL-
glucuronide,  α−BOL-sulphate and  β−BOL sulphate were never found. The 
authors concluded that the presence in urine of unconjugated  β−BOL 
and  α−BOL conjugates next to  α−BOL are no indicators of illegal 
administration, but no indications were obtained about the origin of 
conjugated  β−BOL. Investigations carried out by Le Bizec et al. (9) showed that 
the marker metabolite ‘‘always detectable whatever the injected boldenone form 
and never observable in the so-called endogenous cases’’ could be  β−BOL 
sulphate. Some doubts however emerged about the oral administration (only 0–
20% eliminated in the sulphate fraction) compared with the IM injection (up to 
about 70%). The mechanisms of production of  α−BOL and  β−BOL, but also 
of ADD and AED, in faeces are unclear, although it has been suggested that 
they arise by microbial transformation of cholesterol or phytosterols in the gut 
(1,7). Indeed, Egorova et al. (10) demonstrated that Mycobacterium sp. VKM 
Ac-1815D strain is able to cleave the side chain of sitosterols giving AED as a 
major product. Barthakur et al. (11) showed the ability of Mycobacterium sp. 
NRRL  Β−3683 to transform  β−sitoterols into ADD, in the presence of a 1(2)-
dehydrogenase. Moreover, Grinenko et al. (12) proved that the transformation 
of a natural sterol mixture into AED under the action of Mycobacterium  
sp. S-905 (VKPM collection) is increased by aeration. This fact could imply that 
transformations of sterols into androgens are favoured in faeces after emission, 
i.e. under aerobic conditions, according to our previous work (6). In order to 
better understand the mechanisms that give raise to false BOL positivity of 
faeces-contaminated urine, it is necessary to study the biotransformations that 
these steroids undergo in faecal matter. We therefore further examined 
biotransformations of  α−BOL,  β−BOL, testosterone (17β-hydroxy-4-
androsten-3-one; T), epitestosterone (17 α−hydroxy- 4-androsten-3-one; ET) 
and the precursors/metabolites ADD and AED in faeces of veal calves using a 
simple in vitro model, followed by analysis with liquid chromatography/ tandem 
mass spectrometry (LC/MS/MS). 
 
 
3.3 Experimental 
3.3.1 Reagents and chemicals 
α-BOL was obtained from Tecna (Trieste, Italy). β-BOL, ADD, AED, T and ET 
were purchased from Sigm  α−Aldrich (St. Louis, MO, USA). Deuterated 
testosterone (Td3) (Sigm  α−Aldrich) was tested as internal standard (see below) 
and norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-one; NETA) (Alltech, 
Deerfield, IL, USA) was used as internal standard. All other chemicals were from 
44 
 
Fluka Chemie GmbH (Buchs, Switzerland). Standard stock solutions in ethanol 
(1 mg/mL) were prepared and stored at -18°C; working solutions were prepared 
daily by dilution of stock solutions with methanol/ water (50:50 v/v).  
3.3.2 Animals 
Faeces from ten male Friesian veal calves, age 90–100 days, fed with milk 
replacer (2.8 kg/calf/day) and corn silage (1.3 kg/calf/day), were studied. The 
lipid content of milk replacer was 20% (35% coconut oil and 65% tallow plus 
lard). The animals were housed in individual stalls in a single cowshed and cared 
for in accordance with EU guidelines approved by the Italian Ministry of Health.  
 
3.3.3 Faeces collection and sample preparation 
Rectal faeces from five veal calves were pooled. From the pooled material 
sample 1.3 g was suspended in 130 mL of 0.9% saline and shaken overnight at 
258C. The suspension was divided into thirteen 10 mL samples: one blank 
(without steroid addition), six controls (held at 808C for 15 min and then spiked 
with a steroid) and six treatments (no heating, spiked with a steroid). A steroid 
(T, ET,   α−BOL,   β−BOL, AED or ADD) was added to each control and to 
each treatment tube to a final concentration of 200 ng/mL (20 mg/g faeces) and 
left at ambient temperature. Samples (1 mL) from each tube were collected at 0, 
0.5, 1, 2, 4, 8, 24 and 48 h later. The samples were heated at 80°C for 15 min to 
inactivate bacteria and centrifuged (1400 g, 10 min). The supernatants were 
diluted 1:2 with methanol/water (50:50 v/v) and 20 mL samples analyzed by 
LC/MS/MS without extraction. This experimental procedure was repeated 1 
week later on a pool of faeces from five different veal calves.  
 
3.3.4 LC-MS/MS 
We used a slight modification of the method described in detail elsewhere.6 The 
LC/MS system consisted of a ThermoFinnigan Surveyor LC pump with 
Surveyor autosampler (San Jose, CA, USA) equipped with a LCQ DECA XP 
Max ion trap mass spectrometer (ThermoFinnigan). The column was a 150 mm 
x 2.1 mm i.d., 5 mm ODS Hypersil-Keystone (ThermoFinnigan) in an oven at 
308C. The mobile phase was water with 0.1% acetic acid (A) and methanol (B), 
flow rate 0.3 mL/min. B was kept at 65% for 1 min, increased to 90% over 7 
min, held at 90% for 1 min, and then reduced to 65% over 1 min. An isocratic 
period of 5 min followed with 65% B. The mass spectrometer was operated in 
positive atmospheric pressure chemical ionization (APCI) mode with capillary 
voltage 31 V, capillary temperature 2208C, discharge current 4.5 mA, vaporizer 
temperature 3508C and sheath and auxiliary gas (nitrogen) flow rates of 20 and 8 
arbitrary units, respectively. Helium was used for collision-induced dissociation; 
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the collision energy setting was 30–42% depending on precursor ion stability. 
The analysis was performed in selected reaction monitoring (SRM) mode and the 
molecular ions and most abundant product ions were identified (Table 1).  
 
Table 1. Major ions in MS/MS SRM mode for steroids analyzed 
 
3.3.5 Method validation 
Thermally treated (15 min at 808C) suspended faeces samples were spiked to 
give known concentrations (1.0, 2.0, 5.0, 10, 50 or 100 ng/mL) of analyte, and 10 
ng/mL of NETA as internal standard and analyzed immediately to produce 
Figure 1. Reconstructed LC/MS/MS chromatogram and corresponding SRM spectrum of a blank 
sample spiked with Td3 showing the loss of three deuterium atoms and detection of T. 
 
matrix calibration curves (three sets of replications on three different days; six 
concentration points for each curve), from which the linearity, precision and 
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accuracy were determined. Limits of detection (LODs) and limits of 
quantification (LOQs) were also estimated by multiplying signal-to-noise levels 
by 3 and 10, respectively, in 20 unfortified samples and then converting the 
mean responses into ng/mL. It was found that regression coefficients (R2) were 
in the range 0.987–0.999 for all analytes. LODs were 0.3 ng/mL for   α−BOL, 
  β−BOL, AED and ADD, and 1.0 ng/mL for T and ET. LOQs were 1.0 
ng/mL for   α−BOL,   β−BOL, AED and ADD and 3.0 ng/mL for T and ET. 
Precisions, expressed as intr  α−day and inter-day coefficients of variation 
(CV%), were 2.6–8.2 and 4.5–11.5, respectively. Accuracy, as percentage 
recovery, was in the range 89–120% for all analytes.  
 
 
3.4 Results and Discussion 
The recent study of Fidani et al. (13) showed that 17 β−hydroxy steroids could 
undergo transformations in poorly conserved equine urine (hence susceptible to 
bacterial contamination). Our previous studies (6, 14) showed similar 
transformations in dried calf faeces. In the present study we further investigated 
the biotransformations that steroids could undergo in calf faeces exposed to the 
environment. We analyzed faecal material after incubation in saline in order to 
eliminate confounding effects due to steroids present in urine. We did not 
perform an extraction step so that the samples could be rapidly prepared for 
analysis; the lack of extraction however entailed low sensibilities. The diluted 
suspensions analyzed had to be spiked with known and relatively high quantities 
of steroids in order to detect transformations. We paid particular attention to the 
choice of an internal standard. Preliminary experiments showed that Td3 could 
transform slowly into unlabelled T (Fig. 1), rendering it unsuitable as an internal 
standard. Further experiments showed that NETA, a 17  β−hydroxy steroid 
whose 17 β−hydroxy group is protected from oxidation by the presence of an 
ethyl group at position 17α, would be a suitable internal standard. The 
chromatograms and mass spectra of the test substances are shown in Fig. 2. We 
did not detect any of the steroids studied in the blank samples; neither did we 
detect any biotransformations in any of the control samples. By contrast the 
treatment samples showed transformations as summarized in Tables 2 and 3.  
The concentrations of control samples analyzed at time 0 were considered as 
100% (untransformed steroids) and all data are reported as percentages of these 
values. The results reported in the tables are expressed as the means of two 
experiments. The 17 β−hydroxy steroids T and   β−BOL underwent the most 
rapid transformations. Only 69% of T (Table 2) remained at time 0, implying  
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Figure 2. Reconstructed chromatograms and MS/MS spectra of faeces suspensions at t=0 of the 
six studied steroids. Each chromatogram is the sum of the SRM transitions reported in Table 1. 
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Table 2. Biotransformations of AED, T and ET 
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Table 3. Biotransformations of ADD, β-BOL and α-BOL 
 
that, in the short time between its addition to the suspension and heat treatment, 
about 30% had transformed. Almost complete oxidation of T to AED  
(17-ketosteroid) had occurred at 2 h. Similar results for T and other 
17 β−hydroxy steroids were obtained by Fidani et al. (13) in equine urine, leading 
these authors to conclude that the activity of environmental bacteria 
contaminating the urine as a result of poor conservation was responsible for the 
oxidation of 17 β−hydroxy steroids. Our previous studies on calf faeces (6,14) 
showed that T was almost always absent from rectal faeces (9 of 10 samples), 
faeces from skin and stalls (14 of 15) and pooled rectal faeces (2 of 3). As is 
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evident from Table 3,   β−BOL transformed more  slowly than T and had only 
completely disappeared from the sample after 24 h of incubation.   β−BOL also 
oxidized to a 17-keto steroid, in this case ADD. The poor stability of   β−BOL 
 is consistent with the work of Nielen et al.,3 who detected   α−BOL and ADD 
in bovine skin swab samples, and in dried faeces scraped from the skin.   β−BOL 
was found only in some of the latter samples. The finding is also in agreement 
with the results of our earlier studies,6,14 in which   β−BOL was absent or 
present in few samples, and was always absent from pooled bovine rectal faeces 
left to dry in air. The 17  α−hydroxy steroids ET and   α−BOL proved to 
be fairly stable and had only diminished to 20–25% of their original levels after 
48 h. After 48 h of   α−BOL incubation, considerable quantities of ADD (22%) 
and ET (68%) had appeared, but only a small quantity of AED (3%), while 
after 48 h of ET incubation only small quantities of ADD, AED and α−BOL 
had accumulated. The main effect of ADD incubation under our experimental 
conditions was production of AED, with maximum peak (7%) after 24 h. A 
similar effect was observed by incubating AED, so that peak concentration 
(11%) of ADD was evident at 24 h. Both these steroids also gave rise to small 
quantities of ET, but only ADD was also able to produce a small quantity of 
  β−BOL at 24 h. By contrast, AED seemed unable to produce T; however, it 
could have been produced and transformed back into AED or ADD (Fig. 
3). The results of these in vitro studies provide indications as to the 
transformations of the studied steroids when present in faecal material, although 
they cannot, of course, indicate how the steroids were originally formed in the 
faeces. Our data further suggest that if urine is contaminated by faecal material, 
steroids present physiologically in the urine (T, ET  and AED) may undergo 
transformations thereby profoundly altering the original hormone profile of the 
urine. In addition, we have previously shown6 that   α−BOL, ET, AED and 
ADD neoformation may occur in dried faecal material. Urine may therefore 
receive doses of these steroids if contamination of urine samples from faecal 
crusts present on the skin or dried faeces in the stall occurs. In any event it is 
likely that faecal contamination also brings cholesterol and phytosterols – 
all potential precursors (10,12,15,16) for the neoformation of the steroids 
investigated in the present study. Our data are therefore consistent with the 
hypothesis that neoformation in urine occurs as a result of faecal 
contamination. An additional implication is that the types and concentrations of 
steroid that may be present in contaminated urine are likely to differ from those 
expected as a result of simple transfer from faeces to urine. 
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Figure 3. Reconstructed chromatograms at t = 24 h of faeces suspensions spiked with 200 ng/mL of 
AED (A) and ADD (B). α-BOL and T were not detected.  
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Figure 4. Hypothesis about possible neoformation and interconversions of steroids in bovine faeces 
(both before and after their emission) and in faeces-contaminated urine. 
 
3.5 Conclusions 
Our simple in vitro system, diluting faeces in saline followed by incubation with 
various steroids, allowed us to observe the transformations of steroids that occur 
normally in faeces after their discharge. Our data point to AED as possibly being 
the pivotal compound giving rise to boldenone in contaminated urine (Fig. 4). 
Firstly, AED is the direct biosynthetic precursor of T, and may also give rise to 
ET; the interconversion of T and ET must occur via AED. Secondly, AED can 
also give rise to ADD, which in turn is the intermediate in the interconversion 
of α−BOL and   β−BOL. We suggest that ET and   α−BOL may also 
interconvert; however, the mechanism/intermediate species remain to be 
identified. To obtain further information, similar studies need to be conducted 
on bovine urine contaminated with fresh, dried, skin crust and stall samples of 
bovine faeces.  
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4.1 Abstract 
Proper storage conditions of biological samples are fundamental to avoid 
microbiological contamination that can cause chemical modifications of the 
target analytes. A simple LC-MS/MS method through direct injection of diluted 
samples, without prior extraction, was carried out to evaluate the stability of 
phase II metabolites of boldenone and testosterone (glucuronides and sulphates) 
in intentionally poorly stored equine urine samples. We considered also the 
stability of some deuterated conjugated steroids, generally used as internal 
standards, like deuterated testosterone and epitestosterone glucuronides, and 
deuterated boldenone and testosterone sulphates. The urines were kept one day 
at room temperature, to mimic  poor storage conditions, then spiked with the 
steroids written above and kept at different temperatures (-18°C, 4°C, room 
temperature). It has been possible to confirm the instability of glucuronide 
compounds when added to poorly stored equine urine samples. In particular, 
both 17ß and 17α-glucuronide steroids were exposed to hydrolysis phenomenon 
obtaining non-conjugated steroids. Only 17ß-hydroxy steroids were exposed to 
oxidation reactions obtaining keto derivates. Instead, 17α-hydroxy steroids 
presented high stability. The sulphate compounds showed a complete stability. 
The deuterated compounds underwent the same behaviour of the unlabelled 
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ones. The transformations were observed in urine samples kept at room 
temperature and 4°C temperature (at a slower rate). No modifications were 
observed in frozen urines. In the light of last results, the immediate freezing at -
18°C of the collected samples and their instant analysis after the unfreezing is 
the proposed procedure for preventing and avoiding the transformations in 
urine, usually due to microbiological contamination.  
 
4.2 Introduction 
The anabolic steroids, the most important drugs tested during racing and 
equestrian events, undergo phases 1 and 2 metabolism reactions. The phase 2 
metabolites arise from the conjugation with glucuronic acid or sulphate, and 
represent the 90% of the excreted steroids(1). To detect anabolic steroids in 
urine, the most developed method involves the enzymatic hydrolysis of 
glucuronides and the chemical hydrolysis of sulphates, followed by analysis of 
the free steroids, by GC-MS2 with prior derivatization steps or by LC/MS (3,4). 
Recent developments in LC/MS methods permit the direct detection of phase II 
metabolites(5,6), leading to increased speed and efficiency of analysis and even 
the potential for track-side drug testing. The first problem to be faced in a 
steroid analysis is the conservation state sample, to prevent and avoid possible 
microbiological contaminations. Microbiological activity seems to depend on 
urine storage temperature, highlighting the necessity to maintain the cold chain 
in order to preserve urine samples unaltered, from the moment of collection to 
that of antidoping analysis(7). It has been verified that steroids conjugates in 
urine samples may undergo chemical modifications caused by bacterial 
contaminations (8-14). A misinterpretation of analytical results can be due to 
metabolic activity of bacteria (15,16). Therefore, to prevent any misinterpretation 
due to alteration of steroid conjugates in urine samples, it is fundamental to 
define suitable storage conditions prior anti-doping and clinical samples analyses. 
Some Authors tried to identify microorganisms potentially involved in the 
alterations of urinary endogeneous steroids profile (17,18). Some different 
studies about conjugate or non-conjugate compounds have been carried out on 
human urine (19-23), but few works on equine urine stability have been 
published yet. In a recent study, we demonstrated that 17β-hydroxy steroids can 
undergo transformations in poorly conserved equine urine (reactive or 
contaminated urine) (24). Therefore, the aim of this study was to develop a rapid 
test to evaluate equine urine reactivity by spiking samples with conjugate steroids 
and by monitoring their derivate products by LC-MS/MS analysis. This control 
could reveal a useful tool to evaluate the proper storage conditions of urine 
samples. 
 
59 
 
4.3 Experimental 
4.3.1 Chemical and reagents 
Deuterated testosterone glucuronide (TGD3), boldenone glucuronide (BG), 
testosterone sulfate (TS), deuterated testosterone sulfate (TSD3), boldenone 
sulfate (BS), deuterated boldenone sulfate (BSD3), deuterated epitestosterone 
glucuronide (EPTG D3) and deuterated epitestosterone (EPT D3) were 
purchased from the National Measurement Institute (Pymble, NSW, Australia), 
testosterone glucuronide (TG), testosterone (T), boldione (BDI), 
androstenedione (AED) and deuterated testosterone (TD3) from Sigma-Aldrich 
(St. Louis, MO, USA), boldenone (BDN), epitestosterone (ET) and α-boldenone 
(αBDN from Sarstedt (Numbrecht, Germany), epitestosterone glucuronide 
(EPTG) from S.A.L.A.R.S (Como, Italy). Methanol, formic acid and water were 
purchased from J.T. Baker (Deventer, Holland). All reagents used were of HPLC 
grade.  
 
4.3.2 Standard solutions 
Stock solutions (1 mg/mL) of all free steroids and conjugates and relative 
deuterated were prepared from dry chemical powder of each analyte by 
dissolving in methanol and stored at -18º C. The working solutions were 
prepared by diluting the individual stock solutions at a concentration of 1 
µg/mL with methanol and stored at -18º C. All certificated standards were 
analysed by the LC-MS/MS developed method to evaluate the absence of 
interferences. 
 
4.3.3 Internal standards  
The IS used were the relative deuterated substances and added at the 
concentration of 100 ng/mL in diluted urine samples.  
 
4.3.4 Samples  
Equine urine samples were stored for 1 day at room temperature to mimic poor 
storage conditions. To evaluate their reactivity towards steroids, 950 µl of urine, 
diluted 1:5 with water, were spiked with testosterone (T) to obtain a 
concentration of 50 ng/mL.24 When the transformation of T into AED was 
observed within 2 hours, the urine was considered “reactive urine”. One 
hundred reactive urine samples were centrifuged at 1500g for 10 minutes, 
filtrated and diluted with distillate water (1:5).  Every diluted urine was divided in 
nine portions of 450 µL, each one spiked with one of the following working 
solutions: TG, TGD3, BG, EPTG D3, EPTG, BS, BSD3, TS, TSD3. Nine 
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samples spiked with one of the nine different analytes were obtained. Three 
groups of these nine samples were prepared and stored at -18°C, 4°C as well as 
at room temperature. These storage temperatures were necessary to evaluate the 
temperature effect related to contaminated urines. The samples were analyzed in 
a time range variable from 10 min to 10 days after spiking. 
 
4.3.5 Instrumentation and operating parameters 
An LTQ linear ion trap mass spectrometry equipped with an ESI source 
(Thermo-Fisher, San Josè, CA, USA) connected to a Surveyor Autosampler MS 
Pump (Thermo-Fisher) was used for all LC/MS analyses.Chromatography 
separation was performed at ambient temperature, in isocratic condition, on a 
reversed-phase Luna® (100 x 2 mm. 3µm; Phenomenex, San Josè, CA, USA) 
equipped with a C18 Guard Column® (4 mm. x 2 mm. id; Phenomenex). The 
mobile phase was composed of 40% formic acid 0,1% (solvent A) and 60% 
methanol (solvent B) at a flow rate of 0,25 mL/min. The injection volume was 5 
µL. The ESI-MS/MS parameters were first optimized by direct injection of each 
compound individually at a concentration of 1 µg/mL at a flow rate of 20 
µL/min. The mass spectrometer was operated, from 2 min to 16 min, in positive 
electrospray ionization MS/MS mode, with full scan product acquisition in the 
m/z 75-350 range for detection of T, EPT, TD3, EPTD3, AED, BDN, BDI, 
αBDN and in the m/z 125-500 range for detection of TG, TGD3, BG, EPTG 
and EPTGD3. For the positive ionization a capillary voltage of 12 V, a spray 
voltage of 4 kV, a capillary temperature of 275 °C were employed. The nitrogen 
sheath, auxiliary and sweep gas were set at 40, 20 and 5 arbitrary units 
respectively. The collision energy setting for the compounds ranged between 
14,5% and 19,5% depending on the stability of the precursor ion. For detection 
of TS, BS, TSD3 and BSD3, the mass spectrometer was operated, from 16,01 
min. to 26 min., in negative electrospray ionization MS/MS mode, with full scan 
product acquisition in the m/z 100-450 range. For the negative ionization, the 
tune parameters are the same of the positive ionization, while the capillary 
voltage was set to -8 V. The collision energy setting for the compounds ranged 
between 23% for boldenone sulphate and his deuterated analogue and 50% for 
testosterone sulphate and his deuterated analogue. Data acquisition for MS/MS 
was performed in 6 time segments shown in Table 1, together with precursors 
and product ions mass to charge ratios and relative abundances. In order to 
obtain data, the Xcalibur® software (version 1.4, Thermo-Fisher) was used. 
4.3.6 Method validation  
The method was validated on blank urine samples sterilized in an autoclave for 
15 min at 121°C to obtain non-microbiologically contaminated samples. After 
sterilization, urine was stored at-18°C. The validation was made by spiking the  
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Compound 
Segments (minutes)  Precursor ions 
(m/z) 
Product ions (m/z)relative abundance 
BG 
1st (2‐5 min.) 
463 [M+H]+ 269100, 28755, 46340, 13515 
BDI  285 [M+H]+  267100, 15165, 12163, 14760 
TG 
2nd (5.01–8 min.) 
465 [M+H]+  289100, 46520, 27120, 25315 
TGD3  468 [M+H]+  292100, 27425, 25615, 46810 
BDN  287 [M+H]+  269100, 13595, 17340, 28710 
AED  287 [M+H]+  97100, 26975, 25145, 10935 
T 
3rd (8.01‐12 min.) 
287 [M+H]+  269100, 13555, 17335, 28725 
TD3  289 [M+H]+  274100, 25690, 9770, 29250 
α−BDN  292 [M+H]+  269100, 13555, 17335, 28725 
EPTG D3  468 [M+H]+  292100, 27415, 4685 
EPTG  465 [M+H]+  289100, 27115, 4655 
EPT 
4th (12.01‐16 min.) 
289 [M+H]+  271100, 25390, 28970, 9725 
EPTD3  292 [M+H]+  274100, 25690, 29270, 9728 
BS 
5th (16.01‐20 min.) 
365 [M‐H]-  350100, 36535 
BSD3  368 [M‐H]-  353100, 36835 
TS 
6th (20.01‐26 min.) 
367 [M‐H]-  352100, 36715, 33710 
TSD3  370 [M‐H]-  355100, 34015, 37015  
 
Table 1: LC/MS-MS precursor ions, product ions and acquisition segments for all considered 
compounds  
 
blank urine samples with TG, BG, EPTG, TS or BS, resulting in five analytical 
series, each series with seven concentration levels (1, 5, 10, 50, 100, 200, 500 
ng/mL) and three samples per concentration level (3 samples x 7 concentration 
levels x 5 series = 105 analyses). As internal standards TGD3 for TG, EPTG D3 
for BG and EPTG, TSD3 for TS and BSD3 for BS were used at the 
concentration of 100 ng/mL. All spiked urine samples were stored at -18°C. The 
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method was evaluated in term of linearity (R2; Regression coefficient), limit of 
detection (LOD; signal to noise ratio equal to 3), limit of quantification (LOQ; 
signal to noise ratio equal to 10) for all compounds. Precision (intra-day and 
inter-day coefficients of variations; CVs) and accuracy (Rec%; percentage 
recovery of the analytical procedure) were evaluated on six samples of each 
analyte (50 ng/mL), on three different days (6 samples x 7 standards x 3 days = 
126 analyses). 
Compound  R2 
LOD 
(ng/mL) 
LOQ 
(ng/mL) 
Intra day CV  Inter day CV  Recovery% 
TG  0.9921  1.5  5.0  5.2  6.8  92 
BG  0.9879  1.5  5.0  4.1  6.0  86 
EPTG  0.9896  0.3  1.0  7.5  6.1  110 
BS  0.9942  0.3  1.0  8.9  11.1  95 
TS  0.9989  0.3  1.0  5.8  7.5  103 
 
Table 2: Validation results for studied conjugated steroids  
 
4.4 Results and Discussion 
The validation results for conjugated steroids are shown in Table 2, while the 
parameters related to free steroids are reported in a previous work (24). The aim 
of this study was to develop a LC-MS/MS method to evaluate the stability of 
conjugated steroids (glucuronides and sulphates), related to urine samples 
conservation. When the reactive urine was stored at room temperature, the 
addition of TG gave rise to the transformation of the glucuronated steroid into 
the free form (T), that was subsequently oxidized into AED: this last 
transformation was already observed (24). These transformations have induced 
studies on other conjugate compounds: BG, EPTG, BS, TS were therefore 
examined. We also tested the stability of deuterated conjugate compounds 
(TGD3, EPTG D3, BSD3, TSD3), usually used as internal standards. The BG 
and TG hydrolysis and the subsequent oxidation of the free compounds were 
observed. Figures 1 and 2 show the hydrolysis of BG and TG into BDN and T, 
and the oxidation of BDN into BDI and of T into AED. We also observed, only 
in some equine urine samples (about the 10%), the production, via T and AED, 
of BDI after spike with TG (Figure 3). In our opinion, this transformation has 
never been noticed in equine urine: till now, no study has been published in the 
international literature. 
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Figure 1. LC-MS/MS chromatograms illustrating transformations in a reactive equine urine sample 
stored at room temperature and analysed in positive mode at 10 (t0), 20 (t1) and 30 (t2) minutes after 
spiking with BG. 
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Figure 2. LC-MS/MS  chromatograms illustrating transformations in a reactive equine urine sample 
stored at room temperature and analysed in positive mode 10 (t0), 20 (t1) and 30 (t2) minutes after 
spiking with TG, showing the transformation of TG into AED with T as intermediate compound. 
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Figure 3. LC-MS/MS  chromatograms illustrating transformations in a reactive equine urine sample 
stored at room temperature and analysed in positive mode 10 (t0), 20 (t1), 30 (t2) and 45 (t3) minutes 
after spiking with TG, showing the transformation of TG into BDI with AED and T as intermediate 
compounds. 
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The same hydrolysis and oxidation occurred when the deuterated compounds 
were tested, too. The loss of a deuterium was also observed in the 
transformation of TD3 into AED D2, due to the oxidation of the hydroxyl 
group in C17 (Figure 4). The aforementioned transformations are illustrated in 
Fig 5 and 6, in terms of full-scan LC-MS/MS spectra and in Figure 7 in terms 
 
Figure 4. LC-MS/MS  chromatograms illustrating transformations in a reactive equine urine sample 
stored at room temperature and analysed in positive mode 10 (t0), 20 (t1), 30 (t2) and 45 (t3) minutes 
after spiking with TGD3, showing the transformation of TGD3 into BDI D2 with AED D2 and TD3 
as intermediate compounds. 
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Figure 5. Full scan MS/MS spectra for TG, T, AED and BDI in a reactive equine urine sample stored 
at room temperature. 
 
 
of chemical structures of involved steroids. The transformations of AED into 
BDI and of AED D2 into BDI D2 can be due to different bacterial species  
present in contaminated urine. No other transformation was observed after  the 
formation of BDI and BDI D2.  In the α-glucuronide compounds (EPTG and 
its deuterated), hydrolysis  was observed, but the 17α-hydroxy steroids produced  
(EPT and its deuterated analogue) did not undergo any oxidation, as is shown   
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Figure 6. Full scan MS/MS spectra for  TGD3, TD3, AED D2 and BDI D2 in a reactive equine urine 
sample stored at room temperature. 
 
for EPTG D3 in Figure 8. This observation confirms the results of our previous 
work in which 17β-hydroxy steroids were transformed into the 17-ketones while 
no oxidation of the respective 17α-hydroxy steroids occurred (24). Regarding 
sulphate conjugate (TS and BS) and their deuterated (TSD3 and BSD3) 
compounds, it was observed during 10 days a total stability without any 
transformation in reactive urine (Figures 9 and 10). All transformations observed 
at room temperature in reactive urine samples were also noticed at 4°C. Among 
the contaminated urine samples stored at -18º C, the stability of all compounds 
was observed, even if, after unfreezing, the transformations could restart. It must 
however be underlined that, when the analysis was performed in the early hours 
after unfreezing, no transformation product was detected. Some considerations  
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Figure 7. Transformations of TG and of TGD3 into BDI and BDI D2  observed in some equine 
reactive urine.  
 
 
 
have to be done about the correlation between time and temperature of 
incubation. The transformations observed in the samples kept at room 
temperature were generally faster than the ones occurred in samples kept at 4°C. 
The transformation times were however very variable: in some samples kept at 
4°C we observed transformation rates similar to that observed  at room 
temperature.  It could be therefore assumed that the transformation rate is 
directly proportional to the bacterial activity amount. Furthermore, the type of 
microbial contamination (i.e. bacteria, moulds, etc.) could affect the analyses 
results. Some urine samples that showed high reactivity during our study were 
exposed to sterilization process. After spiking with the studied compounds no 
chemical transformation was observed. This is an evidence that microbial 
contamination of urine is responsible of the observed transformations. 
 
4.5 Conclusions 
The conservation procedure for biological samples is important and 
fundamental, starting from the sample collection to the analysis. In this study we 
showed that the correct determination of phase II metabolites of boldenone and 
testosterone in biological fluids depends on proper storage conditions.  
Among steroids compounds, the results confirmed the instability of glucuronide 
compounds when added to poorly stored equine urine samples and in the same 
time the stability of sulphate compounds. In particular, the 17ß-glucuronides 
were exposed to hydrolysis phenomenon and successively to oxidation reactions 
into 17 keto derivates. Concerning 17α-glucuronides, the hydrolysis  
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Figure 8 LC-MS/MS  chromatograms illustrating transformations in a reactive equine urine sample 
stored at room temperature and analysed in positive mode at 10 (t0), 20 (t1) and 30 (t2) minutes after 
spiking with EPTGD3.  
 
phenomenon carried out to 17α-hydroxy steroids derivates which presented 
high stability. Moreover, the same results were also obtained for the deuterated 
compounds. Total stability was evident in sulphate conjugate and their  
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Figure 9. LC-MS/MS  chromatogram of a reactive equine urine sample stored at room temperature 
and analysed in negative mode 72 hours after spiking with TS and TSD3, and corresponding full scan 
MS/MS spectra. 
 
deuterated compounds. To determine the storage condition of biological 
samples, the principal markers were the transformations of the 17ß and 17α-
glucuronides. It was also observed that the sample conservation at 4°C was not 
sufficient to avoid the chemical transformations, while the conservation at -18°C 
temporally stopped the substrate reactivity. To prevent the analytes 
transformations in biological samples, the suitable procedure is the sterilization; 
otherwise, this is an expensive and long process to be used in a routine activity. 
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Therefore the immediate freezing of the collected samples and their instant 
analysis after the unfreezing is the proposed procedure. 
 
 
 
 
 
 
Figure 10. . LC-MS/MS  chromatogram of a reactive equine urine sample stored at room temperature 
and analysed in negative mode 72 hours after spiking with BS and BSD3, and corresponding full scan 
MS/MS spectra. 
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5.1 Abstract 
Given the close resemblance of the ring A structure of prednisolone and 
prednisone on the one hand, and of androstadienedione on the other, the 
transformation of cortisol and cortisone into prednisolone and prednisone in 
cattle faeces was evaluated. A simple method that does not involve extraction 
but only the 1:100 dilution of cattle faeces, spiking with 400 ng/mL cortisol, 
cortisone or cortisol glucuronide and incubation of the suspension, was used. 
The analyses were performed by HPLC-MS3 to detect the supposed Δ1 
dehydrogenation of the glucocorticoids. The decision limits (CCα) and detection 
capabilities (CCβ) were 2.0 and 3.0 ng/mL for cortisol, cortisone and 
prednisolone, 3.0 and 4.0 ng/mL for cortisol glucuronide and 7.0 and 10.0 
ng/mL for prednisone, respectively. Intrα−day and inter-day coefficients of 
variation (CV%), were 5.6–6.2 and 5.2–6.6 for cortisol glucuronide, cortisol, 
cortisone and prednisolone, and 16.0 and 16.2 for prednisone, respectively. The 
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recoveries were in the range 110–143% for all analytes. Regression coefficients 
(R2) were in the range 0.996–0.999 for all analytes. The results show the 
hydrolysis of the conjugated form and the dehydrogenation in ring A in diluted 
faeces. It is therefore predicted that urine contaminated with faeces may be 
positive for prednisone and prednisolone in the same way as they are positive for 
boldenone, i.e. as a result of microbiological dehydrogenase activity on cortisol 
and cortisone. 
 
5.2 Key words 
 Cortisol, cortisone, prednisolone, prednisone, bovine faeces, HPLC-MS3. 
 
5.3 Introduction 
Prednisolone is a glucocorticoid and its structure differs from cortisol by the 
double bond in position 1 of ring A of the steroidal nucleus of the molecule. The 
same difference exists between prednisone and cortisone (Table 1).  
In 1955, Bunim et al. reported that prednisone and prednisolone possess 
increased anti-inflammatory properties (about four-fold higher (1)) in 
comparison with cortisone and cortisol (2). In the same year Nobile and co-
workers discovered that the oxidation of the latter two corticosteroids by 
Corynebacterium simplex can be used to prepare their Δ1 dehydrogenated 
analogues (3, 4). The microbiological introduction of the double bond in 
position 1,2-(Δ1) of the steroid structure is still used for the production of 
prednisone and prednisolone, as the chemical route is inferior in both product 
purity and yield (5,6). 
In the EU, the use of corticosteroids in livestock is indicated for therapeutic 
reasons only and is regulated by the Council Regulation (EEC) N° 2377/90 (7) 
and the subsequent updates: maximum residue limits (MRLs) for betamethasone 
in cattle and pigs (from 0.75 µg/Kg in muscle to 2.0 µg/Kg in liver) (8), 
dexamethasone in cattle, pigs, horses (from 0.75 µg/Kg in milk to 2.0 µg/Kg in 
liver) (9) and goats (from 0.75 µg/Kg in cow’s and goat’s milk to 2.0 µg/Kg in 
liver) (10); methylprednisolone (not for use in milk producing animals; 10 µg/Kg 
in all tissues) (11) and prednisolone (from 4 μg/kg in muscle and fat; to 10 
μg/kg in liver and kidney) (12) for cattle are indicated in Annex I. No MRLs are 
indicated for prednisone, even though the European Agency for the Evaluation 
of Medicinal Products (EMEA) has reported the interconversion of 
prednisolone and prednisone in cattle (13). 
The Italian National Residue Program (PNR) follows the indications of the 
European Directives 96/22/EC (14) and 96/23/EC (15): corticosteroids, like 
anabolic steroids, are therefore categorized in class A3 (substances having an 
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anabolic effect and unauthorized substances/steroids) when a therapeutic use 
has not been declared in advance by the farm veterinary surgeon.  
The close relationship between serum levels of cortisol, its metabolites and 
stress, makes necessary their measurement in urine or faeces, to avoid stressful 
blood sampling (16). Poor literature data about the faecal elimination of cortisol 
in farm animals however exist: 40% of the cortisol is voided in sheep faeces as 
tetrahydrocortisol, tetrahydrocortisone and cortolones as well as C19O3 steroids 
(17), the proportion of excretion via faeces is 28% in sheep, 41% in horses and 
7% in pigs (18), the predominant faecal metabolites in sheep are unconjugated 
steroids (19), and 11,17 dioxoandrostane (11,17 DOA) concentrations increase 
in cow faeces after a 2 h road journey (16). All these studies report very low 
concentrations, or the absence of cortisol and cortisone in faeces. In our 
previous studies it was demonstrated that a “natural” presence of boldenone can 
be detected in veal faecal matter or in faeces-contaminated urine. This 
androgenic steroid was a product of androstadienedione (ADD) reduction of the 
17-keto group; in its turn, ADD, through a microbiological dehydrogenase, was 
probably produced from androstenedione (AED), the physiological precursor of 
testosterone (20, 21, 22). When the   Α−ring of the steroidal nucleus is 
considered, the difference between cortisol and prednisolone, and between 
cortisone and prednisone, i.e. the double bond in position 1-2, is the same as 
that between testosterone and boldenone or between AED and ADD (Table 1). 
The attractive supposition that faecal contamination of urine could lead to the 
transformation of cortisol into prednisolone and cortisone into prednisone, a 
dehydrogenation process analogous to the one previously observed with 
anabolic steroids, led us to utilize a previously tested effective in vitro 
methodology, involving the incubation of saline-suspended faeces spiked with 
the examined substances and analysis after a cleanup centrifugation (22).  
5.4 Experimental 
5.4.1 Reagents and chemicals 
Cortisol, cortisone, prednisolone, prednisone, and flumethasone (as an internal 
standard) were purchased from Sigma-Aldrich (St. Louis, MO, USA), and 
cortisol glucuronide from Steraloids (Wilton, NH, USA). All other chemicals 
were from Fluka Chemie GmbH (Buchs, Switzerland). Standard stock solutions 
in ethanol (1 mg/mL) were prepared and stored at –18 °C; working solutions 
were prepared daily by dilution of stock solutions with methanol/water (50:50 
v/v). 
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Table 1. Structures of the studied free glucocorticoids and testosterone, androstenedione (AED), 
boldenone and androstadienedione (ADD).  
 
 
1-2 SINGLE BOND 
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1-2 DOUBLE BOND 
 
   
 
Prednisolone 
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Boldenone 
 
 
ADD 
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5.4.2 Animals 
Faeces from 24 male Friesian veal calves, age 120–140 days, were studied. The 
animals were housed on farms in North Italy in individual stalls and were cared 
for in accordance with EU guidelines approved by the Italian Ministry of Health. 
 
5.4.3 Faeces collection and sample preparation 
Eight pools of rectal faeces, each one from three veal calves, were prepared. 
From each pooled material sample, 1.2 g was suspended in 120 mL of 0.9% 
saline and shaken overnight at 25 °C. The suspension was divided into four 30 
mL samples: one blank (without the addition of glucocorticoid) and three 
treatments (cortisol, cortisone or cortisol glucuronide) to a final concentration of 
400 ng/mL (40 µg/g faeces) and allowed to stand at ambient temperature. 
Internal standard flumethasone was added to the blank and the treatments. 
Samples (1 mL) from each tube were collected 0, 1, 2, 4, 8 and 24 h later after 
shaking. The samples were heated at 80 °C for 15 min to inactivate bacteria and 
centrifuged (3000 g, 15 min). Twenty µL of the supernatant were analysed by 
LC-MS3 without extraction. 
 
5.4.4 LC-MS3 
Mass spectra were recorded using a LCQ DECA XP Max ion trap mass 
spectrometer equipped with a Surveyor LC pump and a Surveyor autosampler 
(ThermoFinnigan, San Jose, CA, USA). The column was a 100 mm x 2.1 mm 
i.d., 3 µm Allure Biphenyl (Restek Corporation, Bellefonte, PA, USA) in an oven 
set at 30 °C. The mobile phase consisted of a mixture of 40% water with 0.1% 
formic acid and 60% methanol (isocratic elution) at a flow rate of 0.2 mL/min. 
The mass spectrometer was operated in negative electrospray ionization (ESI - ) 
mode with the following conditions: sheath and auxiliary gas (nitrogen) flow 
rates of 40 and 18 arbitrary units, respectively; spray voltage 5.50 kV; ion transfer 
capillary temperature 245 °C, capillary voltage –23 V; tube lens offset –77V. 
Helium was used for collision-induced dissociation. The analysis was performed 
in consecutive reaction monitoring (CRM) mode, and for the free forms, the 
formation of formiate adduct molecular ions [M+HCOO]- was observed, and 
the transitions to product ions were monitored, as reported in Table 2. The data 
acquisition software was Xcalibur® (ThermoFinnigan, San Jose, CA, USA). 
5.4.5 Method validation 
Thermally treated (15 min at 80 °C) suspended faeces samples were spiked to 
give known concentrations (1.0, 2.0, 10, 50 or 100, 200 and 500 ng/mL) of  
analyte and of internal standard (flumethasone, 10 ng/mL), were analysed 
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Table 2. Major ions in consecutive reaction monitoring (CRM) mode for glucocorticoids 
analysed (C.E.: collision energy; r.a.: relative abundance) 
 
 
immediately to produce matrix calibration curves (three sets of replicates on 
three different days; seven concentration points for each curve), from which the 
linearity, precision and recovery were determined. The noise level was estimated 
using 20 unfortified samples. The decision limit (CCα) and the detection 
capability (CCβ) were calculated and approximated by excess to the next highest 
integer. It was found that regression coefficients (R2) were in the range 0.996–
0.999 for all analytes. The decision limits were 2.0 ng/mL for cortisol, cortisone 
and prednisolone, 3.0 ng/mL for cortisol glucuronide and 7.0 ng/mL for 
prednisone. The detection capabilities were 3.0 ng/mL for cortisol, cortisone 
and prednisolone, 4.0 ng/mL for cortisol glucuronide and 10 ng/mL for 
prednisone. The precision, expressed as intr  α−day and inter-day coefficients of 
variation (CV%), was 5.6–6.2 and 5.2–6.6 for cortisol glucuronide, cortisol, 
cortisone and prednisolone, and 16.0 and 16.2 for prednisone, respectively. The 
recoveries, with reference to the internal standard, were in the range 110–143% 
for all analytes. 
 MS2 MS3 
Compound (MW) Parent m/z C.E. % Parent m/z r.a. C.E. % Product ions m/z r.a. 
Prednisolone (360) 405 25 32943 25 313100 29567 28017 18742 
Cortisol (362) 407 35 33120 25 31590 297100 18910  
Prednisone (358) 403 50 32715 35 30913 299100 28513 20133 
Cortisone (360) 405 60 32934 28 31117 301100   
Cortisol 
glucuronide (538) 
537 40 33110 25 31541 297100 18914  
Flumethasone (410) 455 30 37920 24 363100 34332 32581  
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5.5 Results 
Figure 1 shows the major transformations undergone by the tested steroids. In 
preliminary tests, conducted in MS2, difficulties in obtaining product ions with 
m/z ratios less than 300 were had, even when using high collision energies.  
There were few product ions, and their m/z values and the retention times of 
prednisolone and cortisol with the chromatographic method used were 
furthermore quite similar: this made unambiguous detection of the analytes 
difficult; as the study concerned the possible transformations of cortisol and 
cortisone, it was therefore very important to detect the smallest concentrations 
of their Δ1 dehydrogenated products, i.e. prednisolone and prednisone, 
respectively. For these reasons the analyses were performed in MS3 mode.None 
of the eight blanks contained glucocorticoids at any sampling point. 
When cortisol was added to the faecal suspension, its concentration decreased to 
nearly 50% (ranging from 9.5 to 358 ng/mL) in 8 h and to 30% (unquantifiable 
traces to 224 ng/mL) in one day (Figure 2A). In 24 h prednisolone gradually 
formed and reached 11% (4.8 to 172 ng/mL) of the initial cortisol 
concentration. Cortisone (traces to 3.6 ng/mL) was detected at all points in two 
samples spiked with cortisol.  
The results were similar when the suspension was spiked with cortisone (Figure 
2B), the rate of transformation of which was higher, as its concentration 
decreased to 10% (traces to 125 ng/mL) of the initial concentration in 24 h. The 
neoformation of prednisone was more rapid but quantitatively comparable (the 
maximum value was nearly 15% at 8 h, ranging from 16.8 to 243 ng/mL) to that 
of prednisolone from cortisol, and these latter two corticosteroids were never 
detected. 
Traces of prednisolone and prednisone were detected 1 h after spiking the faecal 
suspensions with cortisol and cortisone, respectively. One cortisol suspension 
showed traces of prednisolone at time 0, while prednisone (at concentrations 
lower than CCβ) was present in four suspensions with cortisone at the same 
sampling point. 
Cortisol glucuronide (Figure 3) decreased by half in 24 h (25.1 to 284 ng/mL) , 
while the free form reached 15% (traces to 212 ng/mL) of the initial conjugate 
concentration. It must be noted that free cortisol was detected in two samples at 
1 and 2 h, and in three samples at two subsequent samplings (maximum 
concentration 3.2 ng/mL), always on day one, when prednisolone traces were 
also detected in six samples. 
Great differences were observed between the 8 pools in detected amounts of 
cortisol, cortisone, prednisone and prednisolone, which resulted in high RSDs, 
as shown in Figures 2 and 3.  
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5.6 Discussion 
Glucocorticoids were never detected in the blank, non-spiked samples, probably 
because of the 1:100 dilution of faeces in saline; nevertheless, in spiked samples, 
traces of glucocorticoids other than the standards used were found at time 0. 
The supplier indicated that the purity of the glucocorticoids in the free form was 
greater than or equal to 98%, without specifying what the impurity could be. An 
analysis of a standard cortisol solution at the concentration of 100 ng/mL was 
performed, to verify whether the other studied corticosteroids were present as 
impurities. Non-quantifiable traces of prednisolone were detected. If the 
decision limits (from 2 to 7 ng/mL), the variabilities (CV values nearly 6%) and 
the concentrations (400 ng/mL) of the corticosteroids studied here are 
considered, the unexpected detection of traces at time 0 is understandable. 
Accordingly, prednisone could constitute a greater impurity in cortisone due to 
its high CCα, while the presence of cortisone at very low levels in two cortisol-
spiked samples was considered to be due to an impurity in the standard used.  
The experimental model used to test the transformation of cortisol and cortisone 
into their Δ1 dehydrogenated derivatives is the first step in attempts to evaluate 
whether prednisolone and prednisone may be considered, like boldenone and 
ADD, as “synthetically produced hormones that are also known to be 
endogenous under certain conditions, dubbed ‘pseudo-endogenous’ or ‘grey 
zone substances’ due to their dual synthetic/endogenous nature” (23). 
The faecal suspensions were therefore utilized as if they were microbiological 
cultures with Δ1 dehydrogenase activity, as proved for a wide variety of 
microorganisms (5). 
As expected, the hydrolysis of cortisol glucuronide was observed, which was 
consistent with previous results obtained in bovine faeces (unpublished work) 
and in poorly conserved equine urine (24), in which the glucuronide forms of 
anabolic steroids underwent hydrolysis into their free forms. 
The transformations of cortisol to prednisolone and of cortisone to prednisone 
are similar to what observed in bovine faeces with respect to the transformation 
of AED to ADD (22) i.e. the introduction of a double bond in position 1,2-(Δ1) 
of the steroid structure. The hydrolysis of cortisol glucuronide is furthermore 
consistent with the data concerning the faecal elimination of unconjugated 
corticosteroids (17, 25); the prednisolone traces found in six samples after one 
day do not indicate with certainty the dehydrogenation of the free form, even if 
this possibility cannot be ruled out. 
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Figure 1 – Representative chromatograms showing the dehydrogenation of cortisol to prednisolone 
(A), cortisone to prednisone (B), and the hydrolysis of cortisol glucuronide to free cortisol (C). 
Cortisol, cortisone and cortisol glucuronide were added to faecal suspensions at a concentration of 400 
ng/mL (t=0) and the transformations were observed for 24 h. 
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Figure 2 – Transformations of (A) cortisol (■) and (B) cortisone (●) in bovine faecal suspensions. All 
the points are reported in the graphs as means and relative standard deviations of eight values and are 
expressed as percentages of the spike concentrations (considered as 100%). (□): prednisolone; (○): 
prednisone. 
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Figure 3 – Transformations of cortisol glucuronide (●) in bovine faecal suspensions. All the points are 
reported in the graphs as means and relative standard deviations of eight values and are expressed as 
percentages of the spike concentrations (considered as 100%). (○): free cortisol. 
 
 
The wide variability observed was due to the well-known inhomogeneity of the 
faeces and also to the different rates of analyte transformation in the different 
samples. This variability makes it difficult to quantitatively describe the observed 
phenomenon.  
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Finally, even though cortisol and cortisone are very frequently absent and only 
sometimes present at very low levels in faeces, the increase in concentration of 
these glucocorticoids in stressful situations, i.e. after transport or at the 
slaughterhouse, should be more accurately quantified. The use of high 
concentrations of these substances to evaluate the supposed Δ1 dehydrogenation 
was therefore decided. This work is the preliminary phase of a huge study on 
cortisol and cortisone transformations that will be performed in vitro on faeces 
and urine, and in vivo on stressed bovines. 
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CHAPTER 6
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You can never foretell 
what any man will do, but 
you can say with precision 
what an average number 
will be up to. Individuals 
may vary but percentages 
remain constant. 
Sherlock Holmes, in Sir Arthur Conan Doyle’s A Study in Scarlet 
 
 
6. Preliminary evaluation on a possible 
transformation of cortisol and cortisone in bovine 
urine after sampling  
6.1 Summary- Cow urines collected in a slaughterhouse and in farms in 
Lombardy were used. The urinary concentration of cortisol was higher than 80 
ng/mL while prednisolone and prednisone were absent (i.e. below the CCa=0.5 
and 0.7 ng/mL, respectively). The transformation of cortisol and cortisone was 
studied by incubating the samples for 1 day at 37°C. The influence of 
deconjugation with β-glucuronidase from Helix pomatia was assessed, too. The 
data obtained demonstrate that a relatively high temperature (e.g. due to 
inappropriate storage conditions or to enzymatic deconjugation), could give 
results that do not represent the effective presence and concentration of the 
abovementioned corticosteroids at the moment of the sample collection. 
 
6.2 Introduction  – In the European Union, the use of corticosteroids in 
livestock is permitted for therapeutic use. The MRLs of prednisolone, whose 
structure is very similar to cortisol, are 4 µg/kg in muscle and fat, 10 µg/kg in 
liver and kidney and 6 µg/kg in milk (1). In Italy, the Netherlands and Denmark 
the corticosteroids are included in group A3 (substances having an anabolic 
effect and unauthorized substances/steroids), because of their steroidal 
structure, whereas others allocate them to B2f (other pharmacologically active 
substances) (2). It has to be noticed that in northern Italy, in the last years, the 
most frequent non compliances are by far due to corticosteroids. In 2007, 18 
bovine farms on 20, showed irregularities for corticosteroids in Piedmont and 
the non compliances of bovine urine were 38 , the 88% of the total, while the 
ones to prednisolone or prednisone were the 70% of the total (3). In Lombardy, 
in the controls made on urine at the slaughterhouse 79 non compliances, 70 due 
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to corticosteroids (89%), and more precisely 65 to prednisolone or prednisone 
(82%) were detected (4). 
The close resemblance of the A ring of prednisolone, prednisone and 
androstadienedione (ADD) on one side, and of cortisol, cortisone and 
androstenedione (AED) on the other side, is shown in Fig 1  
Taking it into account, together with the observation that a previous work, 
concerning the transformations of anabolic steroids in equine urine, showed that 
from testosterone, boldenone could be produced, via its transformation into 
AED that dehydrogenated in position 1,2 of the ring A to give ADD (5 – 
chapter 4) and with the data from Piedmont ant Lombardy, the possible 
transformation of cortisol and/or cortisone into prednisolone/prednisone were 
studied.  
 Figure 1. Chemical structure of the four corticosteroids studied in this work and of the anabolic 
steroids previously studied, showing their similarities in Ring A.  
 
 
 
 
 
6.3 Experimental  
6.3.1Reagents and chemicals  
Cortisol, cortisone, prednisolone, prednisone, flumethasone (as an internal 
standard) and β-glucuronidase from Helix pomatia were purchased from Sigma–
Aldrich (St. Louis, MO, USA). All other chemicals were from Fluka Chemie 
GmbH (Buchs, Switzerland). Standard stock solutions in ethanol (1 mg/mL) 
were prepared and stored at −18°C; working solutions were prepared daily by 
dilution of stock solutions with methanol:water (50:50, v/v). 
6.3.2 Sample collection and preparation 
In a first trial, the urines from 7 Holstein-Friesian cows, aged 27 to 80 months, 
were used. Five samples were from the slaughterhouse and two samples from 
                                                 
          ANDROSTENEDIONE                  ANDROSTADIENEDIONE 
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two farms; all the facilities were in Lombardy. The samples, cooled at 4°C were 
carried to the laboratory and frozen at -18°C. In a second trial the urines from an 
Holstein-Friesian cow were collected at the farm and at the slaughter, with the 
aim to verify if β-glucuronidase from Helix pomatia, often used to catalyze the 
deconjugation of corticosteroids, could induce unwanted transformations, as 
described regarding the production of AED from testosterone (6). 
For the first study, 20 mL of each urine sample, underwent an incubation in a 
shaking water bath kept at 37±1°C. Collection of 2 mL portions were made at 0, 
1, 2, 4, 8 e 24 hours. 
In the second trial, from each sample 3 portion of 2 mL were obtained: one 
portion was immediately extracted while two portions were in advance incubated 
at room temperature overnight. One of these last two portions contained 100 µL 
of β-glucuronidase.  
 
6.3.3 Sample extraction 
To each 2 mL sample, 10 ng/mL of internal standard (flumethasone) and 4 mL 
of a mixture of tert-Buthylmethylether:Ethylacetate (80:20) were added. After a 
20 min shaking in vertical rotary shaker, the samples were centrifuged for 20 min 
at 2000 g. The upper organic layer was collected and dried under vacuum in a 
centrifugal evaporator . The residue was dissolved in 200 µL of a mixture 
methanol:aqueous formic acid 0,1 % (50:50 v/v) and transferred in autosampler 
vials. 
 
6.3.4 LC-MS3 analysis. 
The method of analysis has already been described in Chapter 5 (7). The analysis 
apparatus consisted of an AS autosampler, an LC pump Surveyor, and of an Ion 
trap mass spectrometer LCQ DECA XP Max (ThermoFinnigan, San Jose, CA, 
USA) operating in negative electrospray mode (ESI-). The chromatographic 
separation was achieved with an Allure Biphenyl 100 mm x 2.1 mm i.d., 3 µm 
(Restek Corporation, Bellefonte, PA, USA) column, kept at 30°C and an 
isocratic elution made with a mixture of aqueous formic acid 0.1%: methanol 
(40:60) having a flow of 0.2 mL/min. The acquisition of data was made in CRM 
(consecutive reaction monitoring) mode, the parent ion was the adduct of the 
corticosteroid molecule with formic acid[M+HCOO]-. In table 1 are reported 
the ions considered . 
 
6.3.5 Method validation 
The method was validated following the Commission Decision 657/2002/CE 
(8) in urine with 6 concentration level, three replicates (0.5, 1.0, 2.0, 10, 50, 100 
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ng/mL) and 10 ng/mL of Internal standard. The mean noise level was estimated 
on 20 unfortified samples. The curves of the four corticosteroids were linear in 
the whole range of concentrations (0.984≤ R2≤0.990). 
The CCα (decision limit) values were 0.4 ng/mL for cortisol, cortisone and 
prednisolone, and 0.5 ng/mL for prednisone; similarly, the CCβ (detection 
capability) values were 0.5 ng/mL and 0.7 ng/mL, respectively. The intra- and 
inter-day CVs were 4.1-9.9 and 11.7-16.8. The recoveries, referred to the Internal 
Standard, ranged between 78 and 87%, except for cortisone, that had a recovery 
value of 114%.  
Table 1. Major ions in consecutive reaction monitoring (CRM) mode for glucocorticoids analyzed 
(C.E.: collision energy; r.a.: relative abundance). Ions used for quantification are reported in bold 
characters. 
 
 
6.4 Results 
The seven urine samples of the first study belonged to a wider batch, made up 
by 60 samples from Lombard slaughters and farms. They were chosen according 
to their prednisolone concentration, that was always lower the CCα value (0.5 
ng/mL), to the absence of prednisone and to the concentration of cortisol, 
always higher than 80 ng/mL. Two samples, one from the slaughter and one 
from the farm, did not show any neo formation. In five samples, prednisolone 
neo formed and the concentration was in the range 1.91-26.1 ng/mL. The 
maximum prednisolone concentration was reached at hours 6 and 24, even if the 
more reactive sample showed an high concentration of prednisolone (>17 
ng/mL) already at the fourth hour. In four samples, the decrease of the 
concentration of cortisol did not correlate to the rise in prednisolone level: two 
 MS2 MS3 
Compound (MW) Parent m/z C.E. % Parent m/z r.a. C.E. % Product ions m/z r.a. 
Prednisolone (360) 405 25 32945 25 313100 29570 28018 18739 
Cortisol (362) 407 35 33122 25 31592 297100 18916  
Prednisone (358) 403 50 32718 35 30915 299100 28511 20136 
Cortisone (360) 405 60 32935 28 31117 301100   
Flumethasone (410) 455 30 37918 24 363100 34334 32585  
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times, indeed prednisolone did not form, and cortisol did not reduce when the 
higher prednisolone neoformation was observed. Cortisone levels decreased in 6  
of 7 samples. All this results are shown in Table 2. 
In the second study, the urine collected in the farm did not hold prednisolone 
and the concentration of cortisol and cortisone were 1.38 and 2.08 ng/mL, 
respectively. The urine collected from the same animal, after the slaughtering 
showed concentration of prednisolone, cortisol and cortisone of 1.98, 66.2 e 
15.2 ng/mL, respectively. When the urine was incubated in the absence of Helix 
pomatia,  the change in the concentration of the three steroids was not  
 
 
Hour  Prednisolone Cortisol  Cortisone  Prednisolone Cortisol  Cortisone
  Animal A  Animal B 
0  0  165  38.8  0  85.1  29.2 
1  1.65  167  36.9  0  72.5  18.9 
2  1.37  144  32.2  0  81.4  24.9 
4  1.18  149  30.5  0  77.5  19.3 
6  1.21  158  31.7  0  87.2  19.2 
24  2.06  148  17.8  0  48.4  8.78 
 
  Animal C   Animal D 
0  0  95.5  40.2  0  85.3  20.7 
1  1.04  82.8  39.6  0  47.8  15.6 
2  1.45  83.6  36.9  0  77.6  28.6 
4  2.67  84.0  31.6  0  63.9  14.7 
6  3.13  110  36.4  1.35  94.1  29.2 
24  2.69  81.6  33.5  4.23  52.8  6.96 
 
  Animal E   Animal F 
0  0  196  125  0  241  110 
1  nc  nc  nc       
2  2.23  171  92.8  0  238  84 
4  23.3  217  123  0  192  67.8 
6  17.5  159  95.9  0  157  58.7 
24  26.1  188  52.3  1.91  125  43.5 
   
  Animal H   
 
Table 2. Changes in cortisol, cortisone and 
prednisolone concentrations (ng/mL) in the 
urine of the seven cows of the first study 
during the 24 hours preservation at 37°C. 
Prednisone was never detected; nc: not 
collected.  
0  0  80.6  21.1 
1  nc  nc  nc 
2  0  42.2  16.7 
4  0  85.7  23.5 
6  0  106  26.1 
24  0  43.8  2.19 
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considered significant, as it was lower than 20%, a value including both inter-day 
and ion trap implicit variability. The incubation with Helix pomatia doubled 
cortisol concentration, both in farm and in slaughter urine, while cortisone 
decreased and prednisolone level did not change in slaughter urine. Prednisone 
was never detected (Table 3). 
 
 
 
 
Prednisolone Cortisol  Cortisone
No incubation 
Farm 0 1.38 2.08 
Slaughter 1.98 66.2 15.2 
Incubation without Helix pomatia 
Farm 0 1.42 2.1 
Slaughter 1.94 53.32 12.97 
Incubation with Helix pomatia 
Farm 0 3.69 2.07 
Slaughter 2.27 138 8.74 
Table 3 – Concentrations of prednisolone, cortisol and cortisone in urine of a cow before and after 
incubation, in presence or in absence of β-glucuronidase from Helix pomatia 
 
6.5 Discussion 
The preservation of urine at 37°C induced the neoformation of prednisolone, 
without correlation to cortisol change in concentration. This fact could be 
interpreted as an evidence that cortisol is present in bovine urine both in its free 
and conjugated form. This last one could partially hydrolyze during incubation at 
37°C, a supposition disagreeing with Antignac et al. (9) who showed that cortisol 
in bovine urine is almost all in its free form (92-98%). Our hypothesis could 
seem confirmed in the second trial. When β-glucuronidase from Helix pomatia 
was used, a noticeable rise in cortisol concentration was detected. The overnight 
incubation without the enzyme, did not induce modifications. This could be due 
to the temperature lower than  that used in the first experiment. 
Finally, further studies are needed to verify if inadequate storage temperatures, 
or the enzymatic deconjugation itself may give result not representative of the 
actual urinary presence or concentration of the studied steroids so that non 
compliances could be incorrectly stated.  
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7.1 Abstract 
After a two-year period of the frequent detection of prednisolone-positive 
bovine urine samples in the Italian region of Lombardy, studies were initiated to 
investigate the source. Because the majority of positive samples were detected at 
the slaughterhouse, researchers hypothesised that, together with increased 
cortisol and cortisone, a small quantity of prednisolone could be produced by 
the cows in stressful situations. In the present study, three dairy cows underwent 
intramuscular treatments with tetracosactide hexaacetate, a synthetic analogue of 
adrenocorticotropic hormone, to simulate stress. The animals were slaughtered 
at the end of the study. The results indicated that prednisolone could be detected 
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occasionally in the non-stressful state, but was consistently found in the urine of 
stressed cows (concentrations ranged from 1.01 to 4.08 ng/mL). To confirm the 
stress condition, urinary cortisol and cortisone were also detected at high 
concentrations in the urine, typically at concentrations of hundreds of 
nanograms per millilitre. The results of this preliminary study did not reveal the 
metabolic pathway responsible for prednisolone  but suggested that this 
corticosteroid could be produced endogenously.  
7.2 Keywords 
 Prednisolone, cow, urine, HPLC-MS3, ACTH 
7.3 Introduction 
Prednisolone (Δ1,4-pregnadiene-11β,17α,21-triol-3,20-dione) is a corticosteroid 
with gluconeogenetic and antinflammatory activities. Prednisone (Δ1,4-
pregnadiene-17α,21- diol-3,11,20-trione), which is the inactive prodrug of 
prednisolone, is enzymatically activated in the liver (1). The adrenocortical 
activities of these two steroids are 3- to 4-times the activity of cortisone or 
cortisol (2). In the European Union, some corticosteroids are permitted for 
therapeutic use in livestock. However, the use of corticosteroids is regulated by 
the Commission Regulation (EEC) N° 37/2010, which sets maximum residue 
limits (MRLs) for betamethasone, dexamethasone, methylprednisolone and 
prednisolone. The use of prednisolone is permitted in cattle, and the MRLs are 4 
µg/kg in muscle and fat, 10 µg/kg in liver and kidney and 6 µg/kg in milk (3). 
The member states are required to monitor the use of pharmacologically active 
substances in animals used for the production of food for human consumption. 
They must follow the indications of Council Directive 96/22/EC (4), which was 
amended by Directive 2003/74/EC (5) and 96/23/EC (6). Because of their 
steroidal structure, the corticosteroids are included in group A3 (substances with 
an anabolic effect and unauthorised substances/steroids) of National Residue 
Control Plan (NRCP) of some member states (Italy, the Netherlands and 
Denmark), whereas other states allocate them to the B2f group (other 
pharmacologically active substances) (7). In Italy the controls on corticosteroids 
use are made at the slaughterhouse and at the farm. In the first case the matrices 
sampled are liver, a target tissue for which MRLs are set, or urine, while at the 
farm the matrix sampled is urine. For this matrix, no maximum allowable 
concentration has been fixed. The 2008 and 2009 Italian NRCP reports (8, 9) 
stated that corticosteroid residues in cattle, particularly prednisolone, were an 
emerging problem. In 2008, the Lombard Veterinary Organisational Unit-
Structure for the Control on Food of Animal Origin (Unità Organizzativa 
Veterinaria-Struttura di Controllo degli Alimenti di Origine Animale) found that 
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the analyses on cow urine made in farms did not give any positivity to 
prednisolone or prednisone. The same analyses for the urine of slaughtered 
cows, however, showed that positive samples accounted for 82% of all 
irregularities (10). Therefore, we hypothesised that the stress evoked by handling 
before slaughter (11) caused prednisolone or prednisone to increase to levels that  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Chemical structures of the four steroids studied. 
 
could be detected using current analytical methods. This stress also increased 
urinary levels of cortisol and its metabolites in cattle. Accordingly, in the present 
study we measured the urinary concentrations of cortisol, cortisone, 
prednisolone and prednisone (Figure 1) in dairy cows before and after 
intramuscular administration of tetracosactide hexaacetate (an 
adrenocorticotropic hormone synthetic analogue), which was used to induce 
stress pharmacologically. The urine of each animal was also analysed after 
slaughter.  
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7.4 Experimental 
7.4.1 Animal treatments and sample collection 
Three healthy Holstein-Friesian lactating cows, aged 44, 60 and 106 months, 
were housed in a Lombard farm and fed with a diet typically used in breeding 
dairy cows. The cows were cared for in accordance with EU guidelines approved 
by the Italian Ministry of Health and maintained under the control of the Istituto 
Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna (IZSLER). 
A 2 mg intramuscular injection of tetracosactide hexaacetate (Sinacthen rp - 
prolonged release - Defiante Farmaceutica S.A., Punchal, Portugal), 
corresponding to 200 I.U. of adrenocorticotropic hormone (ACTH), was 
administered twice at an interval of 24 hours. Urine samples were collected 
(urethral catheterisation) at the farm 24 and 48 hours before the first treatment, 
and 2, 7 and 24 hours after the second treatment. The last collection at the farm 
was made 2 hours before transport to the slaughterhouse (46 hours after the 
second treatment), and another sample was collected directly from the urinary 
bladder immediately following the slaughter. After collection, the urine samples 
were frozen at -18°C, carried to the Toxicology Laboratory of the Department 
of Veterinary Sciences and Technologies for Food Safety at the University of 
Milan and stored at -18°C.  
7.4.2 Reagents and chemicals  
Cortisol, cortisone, prednisolone, prednisone and flumethasone (as an internal 
standard) were purchased from Sigma–Aldrich (St. Louis, MO, USA). All other 
chemicals were from Fluka Chemie GmbH (Buchs, Switzerland). Standard stock 
solutions were prepared in ethanol (1 mg/mL) and stored at −18°C. Working 
solutions were prepared daily by diluting the stock solutions with methanol:water 
(50:50 v/v). 
7.4.3 Sample preparation 
Two millilitres of urine was spiked with the flumethasone internal standard (10 
ng/mL), and 4 mL of a mixture of tert-butyl methylether:ethyl acetate (80:20 
v/v) was added in a 15-mL polypropylene tube. After shaking in a vertical rotary 
shaker for 20 minutes, the sample was centrifuged at 3000 x g for 15 minutes. 
The upper organic layer was collected with a Pasteur pipette, transferred to a 10-
mL glass tube and dried under vacuum in a centrifugal evaporator. The residue 
was dissolved in 200 µL of a mixture of methanol-aqueous formic acid (0.1%, 
50:50 v/v) and transferred to vials for LC-MS3 analysis. 
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7.4.4 LC–MS3 analysis  
Analysis was carried out with a Thermo Finnigan HPLC system (Thermo 
Electron, San Jose, CA, USA) consisting of a Surveyor LC quaternary pump 
equipped with a degasser and a Surveyor AS autosampler. Chromatographic 
separation was performed using a reversed-phase HPLC column (100 mm × 2.1 
mm i.d., 3 µm Allure Biphenyl) (Restek  Corporation, Bellefonte, PA, USA) in an 
oven set at 30°C. The isocratic elution was achieved with a mixture of 40% 
aqueous formic acid (0.1%) and 60% methanol at a flow rate of 0.2 mL/min. 
The Thermo Finnigan LCQDecaXpMax ion trap mass spectrometer (Thermo 
Electron, San Jose, CA, USA) was operated in negative electrospray ionisation 
(ESI-) mode with the following conditions: sheath and auxiliary gas (nitrogen) 
flow rates of 40 and 18 arbitrary units, respectively; a spray voltage of 5.50 kV; 
an ion transfer capillary temperature of 245°C; a capillary voltage of −23 V; and 
a tube lens offset of −77 V. Helium was used for collision-induced dissociation. 
All investigated compounds showed, in full scan MS, very abundant formiate 
adducts ([M+HCOO]-). Consequently these ions were used as precursor ions for 
the MS2 fragmentation: for each analyte, the most abundant ion detected after 
the collision, was then used as precursor for the MS3 fragmentation . The 
analysis was performed in consecutive reaction monitoring (CRM). Precursor 
ions, product ions and collision energies are shown in Table 1 The 
quantifications were preferably made on one ion that did not show interferences 
either due to matrix or other analytes. Prednisone and cortisone requested the 
Table 1. Major ions in consecutive reaction monitoring (CRM) mode for the 
analysed glucocorticoids (C.E.: collision energy). The most abundant ions are 
underlined, and the bolded ions were used for quantification.  
 
use of two ions, in order to rise the method sensitivity, while the internal 
standard area was calculated on three ions, as no interferences were observed. 
 MS2 MS3
Compound (MW) Precursor m/z C.E. % 
Precursor 
m/z C.E. % Product ions m/z 
Prednisolone (360) 405 25 329 25 313 295 280 187
Cortisol (362) 407 35 331 25 315 297 189 
Prednisone (358) 403 50 327 35 309 299 285 201
Cortisone (360) 405 60 329 28 311 301  
Flumethasone (410) 455 30 379 24 363 343 325 
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Representative chromatograms and mass spectra with diagnostic ions of the 
studied steroids and the internal standard are shown in Figure 2. XcaliburTM 
data acquisition software from Thermo was used. 
 
Figure 2. Reconstructed chromatograms and MS3 spectra of the four studied 
corticosteroids (10 ng/mL) and the internal standard (100 ng/mL) dissolved in 
methanol:H2O (50:50). Each chromatogram is the sum of the diagnostic ions 
reported in the corresponding spectrum. 
 
 
7.4.5 Method validation 
The method was validated according to the Commission Decision 2002/657/EC 
(12). Blank urine samples were spiked to achieve known concentrations (0.5, 1.0, 
2.0, 10, 50, 100 ng/mL) of analyte and internal standard (flumethasone, 10 
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ng/mL). These samples were analysed to generate matrix calibration curves 
(three sets of replicates on two different days for a total of six concentration 
points for each curve), which were used to determine the linearity, precision and 
recovery. The noise level was estimated using 20 unfortified samples. The 
decision limit (CCα) and the detection capability (CCβ) were also calculated. We 
found that the curve was linear in the concentration range tested (0.984≤ 
R2≤0.990 for all analytes). The decision limits were 0.5 ng/mL for prednisone 
and 0.4 ng/mL for cortisol, cortisone and prednisolone. The detection 
capabilities were 0.7 ng/mL for prednisone and 0.5 ng/mL for cortisol, 
cortisone and prednisolone. The precisions, expressed as intra-day and inter-day 
coefficients of variation (CV%), was 4.1-9.9 e 11.7-16.8, respectively. With 
respect to the internal standard, the recoveries ranged between 78 and 87%, 
except for cortisone, which demonstrated a value of 114%.  
7.5 Results 
The data obtained in the present study are presented in Table 2.  
Hours from the treatment Cow 1 (age 44 months) Cow 2 (age 60 months) Cow 3 (age 106 months)
P F E P F E P F E 
-48 (at the farm) nd 1.98 1.15 nd 6.25 3.87 nd 4.41 2.09
-24 (at the farm) nd 6.92 4.29 nd 10.6 6.48 0.53 15.9 8.7
+2 (at the farm) 1.01 238 141 2.41 232 105 3.51 163 55.4
+7 (at the farm) 1.63 248 127 1.27 294 137 3.08 196 79.8
+24 (at the farm) 0.69 25.3 6.34 nd 12.3 6.77 nd 2.07 2.01
+46 (at the farm) nd 0.65 1.21 1.91 35.2 15.8 nd 5.81 2.31
+48  (after slaughter) 2.6 150 51.9 4.08 271 126 1.1 64.2 29.9
 
Table 2. Concentrations of corticosteroids (ng/mL) detected in urine samples  (P: 
prednisolone; F: cortisol; E: cortisone; nd: not detected). Prednisone was never detected.  
The samples that were collected before the first intramuscular injection of 
tetracosactide hexaacetate showed urinary cortisol levels ranging from 1.98 to 
15.9 ng/mL and  cortisone levels ranging from 1.15 to 8.7 ng/mL. Prednisolone 
was detected in the urine sample from cow 3 that was collected 24 hours before 
the first administration of tetracosactide hexaacetate. When the three cows were 
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pharmacologically stressed, prednisolone was consistently detected in the urine 
both 2 hours and 7 hours after the second intramuscular injection. 
Concomitantly, the urinary level of cortisol increased to values ranging from 163 
to 294 ng/mL. We also observed an increase in cortisone levels, which 
demonstrated concentrations that were approximately one-third to one-half of 
the cortisol levels (55.4 to 137 ng/mL). The concentrations of cortisol and 
cortisone at 24 and 46 hours post-stress were similar to those before 
tetracosactide hexaacetate treatment. Prednisolone was detected in two of six 
samples, in two different cows, and at different collection times. At the 
slaughterhouse, however, prednisolone was detected in all urine samples. The 
cortisol and cortisone concentrations and ratios after slaughter were similar to 
the concentrations observed after tetracosactide hexaacetate treatment. 
Prednisone was never detected. Representative chromatograms and mass spectra 
of urine samples collected from cow 1 twenty-four hours before the first 
treatment, two hours after the second treatment and after slaughter are 
presented in Figures 3, 4 and 5 respectively. In Figure 6, the reconstructed 
chromatograms of three diagnostic ions of prednisolone, detected in urine from 
the same animal and corresponding to the samples presented in Figure 4 and 5, 
are shown. Because of the unusual results observed in the present study, we 
asked the Drug Residue Laboratory of the official organisation IZSLER and the 
official anti-doping laboratory for sport horses U.N.I.R.E. Lab. Srl, to test our 
urine samples for the presence of prednisolone to confirm our results. The 
results of the analyses, performed by the U.N.I.R.E. laboratory, only through 
qualitative determination, fully confirmed the ones reported in this work. The 
IZSLER laboratory otherwise did not confirm prednisolone presence in sample 
collected from cow 3, 24 hours before first tetracosactide hexaacetate 
administration, and from cow 1 urine collected 24 hours after second injection. 
The analyses were carried out in the IZSLER laboratory applying a confirmatory 
method fully validated according to the Commission Decision 2002/657/EC 
(12), with a triple quadrupole mass spectrometer and at U.N.I.R.E. Lab. Srl 
applying a method with a linear trap mass spectrometer. In both laboratories 
solid phase extraction(SPE) was used to purify the sample. To confirm that the 
identification of prednisolone made by three laboratories operating with low 
mass resolution spectrometers was correct, a further analysis was made on the 
urine sampled from cow two 46 hours after 
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Figure 3. Reconstructed chromatograms and MS3 spectra of prednisolone, 
cortisol and cortisone detected in the urine of cow 1 twenty-four hours before 
the intra muscular  injection of tetracosactide hexaacetate. ). Each chromatogram 
is the sum of the diagnostic ions reported in the corresponding spectrum.  
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  Figure 4. Reconstructed chromatograms and MS3 spectra of prednisolone, 
cortisol and cortisone detected in the urine of cow 1 two hours after the second 
intra muscular injection of 2 mg of tetracosactide hexaacetate. ). Each 
chromatogram is the sum of the diagnostic ions reported in the corresponding 
spectrum.  
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Figure 5. Reconstructed chromatograms and MS3 spectra of prednisolone, 
cortisol and cortisone detected in the urine of cow 1 after slaughter. Each 
chromatogram ). Each chromatogram is the sum of the diagnostic ions reported 
in the corresponding spectrum.  
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Figure 6. Reconstructed chromatograms of three diagnostic ions of prednisolone 
detected in the urine of cow 1 two hours after the second intramuscular injection 
of tetracosactide hexaacetate (A) and after slaughter (B). In the last row the 
chromatograms of the internal standard are reproduced.  
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the second treatment and from cow three after slaughter. These samples, after a 
SPE clean up, were sent to the laboratories of Waters Corporation in 
Manchester (UK), to be analyzed with a Xevo QTof. The results fully confirmed 
the presence of prednisolone in the two urine samples, through the accuracy of 
the measured masses both of the acetate precursor ([M+CH3COO]-) in MS 
analysis, as shown in Figure 7, and of the product ions in MS/MS analysis. 
 
Figure 7. Tof spectra of the prednisolone peak detected in the urine samples 
from cow two 46 hours after the second treatment (A) and cow three after 
slaughter (B). The exact mass of prednisolone acetate ([M+CH3COO]-) is 
419.2070 Da. 
 
7.6 Discussion 
No evidence was found in the literature about a possible endogenous production 
of prednisolone in mammals. However, some indications could be determined a 
posteriori. Gotzmann et al. studied the kinetics of prednisolone in 20 horses and 
concluded that metabolites of prednisolone-21-acetate (20α- and 20β-
dihydroprednisolone) were detected in urine 732 hours after an intra muscular 
injection. The data regarding the presence of prednisolone, however, were 
incomplete because of a peak originating from the biological matrices, while 
prednisone was detectable in two horses at the last collection time. Because the 
prednisolone metabolites were still detected long after the administration of 
prednisolone-21-acetate, an endogenous presence of prednisolone could be 
hypothesised  also considering that the collection made at 732 hours was the last 
one and no data are reported on urinary levels after this collection time (13). A 
recent study presented an LC-MS/MS method to determine six corticosteroids 
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in bovine urine, and four samples of cow urine from the 2008 Hungarian residue 
control monitoring program were (presumably randomly) subjected to analysis 
to test the method. Prednisolone was the only corticosteroid detected in all four 
samples, and its concentration ranged from 0.3 to 0.9 ng/mL (14). The present 
study was performed to investigate data from the Official Residue Control 
Program of the Lombard veterinary organisational unit and to attempt to 
understand their observation of a high frequency of prednisolone-positive 
samples in slaughtered cows: in this respect, we considered appropriate to use 
three healthy lactating dairy cows of different ages, as in farms can be found. We 
did not try to make any conclusions about the physiological levels of cortisol and 
cortisone in bovine urine as well. Nevertheless, some considerations are 
proposed regarding this topic. When the cows were in supposed non-stressful 
conditions, the higher urinary concentrations of cortisol and cortisone were 35.2 
and 15.8 ng/mL, respectively. These concentrations where however only found 
in the urine sample collected 46 hours after treatment from cow 2. In this sample 
all the laboratories detected prednisolone. This finding could represent the 
evidence of an uncontrolled stress condition of this cow. Regarding the samples 
with a doubtful presence of prednisolone (urine collected 24 hours before the 
treatment from cow 3 and urine collected 24 hours after the treatment from cow 
1), two considerations are to be made: the concentrations of this steroid were 
very close to our CCβ (0.5 ng/mL) and to the CCα of the IZSLER Laboratory 
(0.58 ng/mL). The concentrations of cortisol were lower than in sample 
collected 46 hours after the treatment from cow 2, but higher than in any other 
sample collected in supposed non-stressful condition; cortisone showed a similar 
behaviour. The two doubt samples could therefore show cortisol and cortisone 
urinary concentrations at which low stress conditions (e.g due to the animal 
handling) exist, but do not induce an indisputable detection of prednisolone in 
urine. The values increased when a stress factor was applied to the cows 
(tetracosactide or transport to the slaughterhouse): cortisol concentrations 
ranged from 64.4 and 294 ng/mL, and cortisone concentrations ranged from 
29.9 and 241 ng/mL. Despite the large amount of variability in the data, the 
concentrations of cortisol and cortisone in the two different conditions did not 
superimpose, which provided evidence that the cows were stressed. The most 
noteworthy result of the present study was that prednisolone was always 
detected in stressed cows. In comparison, prednisolone was undoubtedly 
detected in 1of 12 samples from supposed non-stressed cows. The possibility of 
a transformation of endogenous corticosteroids, such as cortisol or cortisone, in 
urine by microorganisms with Δ1 dehydrogenase activity has been previously 
studied (15). Considering the precautions that were taken for the collection 
(urethral catheterisation at the farm and directly from the urinary bladder at the 
slaughterhouse) and storage (immediate freezing at -18°C), the detection of 
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prednisolone in our samples cannot be explained by faecal (16) or massive 
microbial contamination. The contamination of urine, however, is an important 
issue because of the presence of microbial elements in the analysis environment. 
Prednisone was never detected, consistent with the ability of mammalian 
organisms to activate this compound to prednisolone in the liver via the activity 
of 11β-hydroxysteroid dehydrogenase (1, 17). The results observed for 
prednisolone in the present study suggested that it is very likely to find this 
corticosteroid in the urine of stressed animals. Our data, however, did not clarify 
whether prednisolone was a metabolite of cortisol or a by-product of its 
metabolic pathway. Moreover, prednisolone could also be detected under 
supposed non-stressful conditions. These considerations should be taken into 
account when setting the controls that are used to determine the illicit use of 
prednisolone. Further studies are needed to clarify the matter and to finally 
confirm the hypothesis expressed in this work.  
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CHAPTER 8
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Stock your mind, stock 
your mind. You might 
be poor, your shoes 
might be broken, but 
your mind is a palace. 
Frank McCourt, Angela's Ashes 
 
 
8.1 Some considerations 
When, from the first noughties onwards, we dealt  with boldenone, and more 
recently we began to study the prednisolone topic, because of the significantly 
difference in the frequency of positivities to these drugs among farm animals’ 
urines, some considerations were made: 
1- Does a benefit come to the farmer from the use of this substances?  
2- Are the concentrations in biological samples consistent with the eventual 
benefits?  
3- Have sampling, transport to the laboratory and storage been properly 
made?  
4- Are the analytical methods and instrumentations changed, so improving 
the sensibility of analyses (a quite rhetorical question)? 
The point is that if any doubt comes from these answers, studies should have to 
be carried out regarding the origin of the presence of the studied substances. 
Boldenone and prednisolone are quite an example of this. In fact: 
1-  No data were found in literature about the efficacy of boldenone as growth 
promoter, except a degree thesis stating that it improves the colour of meat, 
but reduces zootechnic performances (1). On the other hand, prednisolone 
has a gluconeogenetic activity equal to four or five times that of cortisol but 
one fifth than that of dexamethasone or betamethasone and its half life is 
shorter than the latter two steroids (Table 1). 
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Table 1 – Relative potencies of commonly used corticosteroids (Modified 
from the Merck Veterinary Manual – online edition) (2). 
 
The data shown in the table would suggest that for an illicit use of a 
glucocorticosteroid as growth promoter, with the aim to increase the 
appetite and the metabolism of an animal, dexamethasone and 
betamethasone would by far be preferable because of their relative 
potencies. The data relative to Lombardy in 2008 show that the positivities 
to glucocorticosteroids were 63 for prednisolone and just 8 for 
dexamethasone, and that these corticosteroids were detected only in cow 
urine. The Italian 2009 national residue control plan (NRCP) shows that 
prednisolone was found 76 times in bovine while dexamethasone and 
betamethasone only 13 and 2 times, respectively (4). 
2-  We had no the official data on concentrations of boldenone or 
prednisolone positive urine, but  personal communications with 
professionals in the field of zoothecnics and control of residues, refer of 
urinary concentrations almost exclusively in the range of ng/ml, levels that 
should mean that the times of treatment before the collection are unlikely 
similar. 
3-  We had no indications on transportation to the laboratories and storage, 
but a previous work indicated the collection condition of urine as the main 
responsible for boldenone detection (5). The data from Italian NRCP of 
2001 and 2002 were reported, and showed that the percentage of urine 
samples found positive for the presence of boldenone were much higher 
when the collection was carried out with a zoonotechnical apron (18.1 % α-
boldenone and 2.1% β-boldenone) than when a kettle upon cleaning and 
trimming of animal sheath area was used (0.2% and 0.0%, respectively) 
(Figure 1). 
 
 
120 
 
Figure 1. Urine samples collected with a zootechnical apron and those 
collected by kettle upon cleaning and trimming of animal sheath area (from 
Reference 5). 
 
The study concluded that the faecal contamination was responsible for the 
different results in the different collection conditions, and that this 
contamination must be avoided to assure an illicit origin of the presence of 
boldenone. 
Has prednisolone a similar origin in bovine urine? In the study reported in 
chapter 5 the transformation of cortisol to prednisolone in bovine faeces 
was tested, has a first step to understand the presence of prednisolone in 
faeces contaminated urine. The conclusion was that: “The transformations 
of cortisol to prednisolone and of cortisone to prednisone are similar to 
what observed in bovine faeces with respect to the transformation of AED 
to ADD (the precursors of testosterone and boldenone, respectively) i.e. 
the introduction of a double bond in position 1,2-(Δ1) of the steroid 
structure”. Furthermore in chapter six a work is related about the 
neoformation of prednisolone in urine after collection. Seven urine samples 
with a high concentration (>80 ng/ml) of cortisol, were incubated at 37°C 
for 24 hours. In 5 samples the neoformation of prednisolone was observed. 
It could represent the proof that not only faecal, but also environmental 
contamination would be responsible of prednisolone presence in urine. In 
other words, bad sampling or inappropriate storage conditions could lead 
to prednisolone non compliant urine samples. 
 
4- Obviously, the analytical methods and the instrumentation performances, 
in time do not get worse: an improvement in sensitivities must always be 
considered. We improved ourselves on prednisolone sensitivities and the 
CCß equal to 0.5 ng/ml reported in this thesis, became 0.22 ng/ml in the 
studies now in progress (personal data).   
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A corticosteroid-peculiar element must be furthermore considered: the stress 
conditions an animal undergoes when transported to the slaughterhouse. 
Someone (6), using a vivid metaphor, defined cortisol (and noradreline) “the 
messenger of the wartime commander” to underline its (their) higher production 
in stress conditions, so that cortisol is also named the stress hormone. In the last 
study performed and reported in Chapter 7, a “collateral” production of 
prednisolone in stressful situations was hypothesized and its presence at 
detectable concentrations in cow urine was demonstrated, both when animals 
were submitted to pharmacological or slaughter stress.  
 
At last, the analogy between prednisolone and boldenone is not restricted to the 
similarity to cortisol and testosterone, respectively. As stated in the foreword, the 
production of cortisol takes place in the zona fasciculata of the adrenal cortex, 
while DHEA and androstenedione, precursors of testosterone, are produced (in 
small amounts in men, but more than 50% in women) also in the zona reticularis 
of adrenal cortex. The secretion of glucocorticosteroids is regulated by ACTH, 
that seems to have a role in androstenedione secretion, too. If a by-production 
of prednisolone(Δ1-2dehydrogenated cortisol) occurs during stress, a similar by 
production of the boldenone precursor androstadienedione, 
(Δ1-2dehydrogenated androstenedione), could be supposed.  This hypothesis 
could be a fascinating topic to be dealt with in future studies on the origin of 
presence of boldenone and prednisolone in bovine urine. 
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This is the end, my only friend, the end 
Of our elaborate plans, the end 
Jim Morrison, The end 
 
Summary 
Two tight correlated topics were dealt in this thesis: 
 
- Bovine urine can result positive for boldenone, an androgenic steroid with the 
structure of testosterone with a double bond in Δ1-2  position of ring A, and 
androstadienedione, its 17-oxidized form, in consequence of faecal 
contamination, mainly through a high neo production in faeces-contaminated 
urine. A simple in vitro method was developed – incubation of faecal matter 
suspended in 0.9% saline – to induce steroid transformations in faeces, and 
analyzed the products by liquid chromatography/tandem mass spectrometry, 
without the need for prior extraction. Androstenedione, androstadienedione, 
  α− and β−boldenone, testosterone and epitestosterone transformations were 
investigated. Mutual interconversions of steroids were observed, although 
17  β−hydroxy steroids had lower stability if compared with 17  α−hydroxy and 
17-keto steroids. This simple in vitro system proved to be an effective way of 
studying hormone transformations in faeces and in faeces-contaminated urine 
(Chapter 3). An analogous method, i.e. the direct injection, for LC/MS-MS 
analysis, of diluted equine urine, without prior extraction, was carried out to 
evaluate the stability of phase II metabolites of boldenone, testosterone and 
epitestosterone (glucuronides and sulphates) in intentionally poorly stored urine. 
Both 17β and 17 α-glucuronide steroids hydrolyzed to their correspondent 
hydroxysteroids, but only the 17 β epimers oxidized to the keto forms. The 
sulphate compounds showed a complete stability. The transformations were 
temperature dependent: faster at room temperature than at 4°C, while did not 
occur in frozen urines. This indicated that proper storage conditions of 
biological samples are fundamental to avoid microbiological contamination that 
can cause chemical modifications of androgen steroids (Chapter 4).  
 
- After a two-year period of the frequent detection of prednisolone-positive 
bovine urine samples in the Italian region of Lombardy, studies were initiated to 
investigate the source. The problem of modifications in biological fluids was 
therefore evaluated also regarding a possible transformation of cortisol and 
cortisone into prednisolone and prednisone in cattle faeces. The transformation 
of the II phase metabolite cortisol glucuronide was studied, too. The method 
consisted once more of incubation of bovine faecal matter suspended in 0.9% 
saline spiked with cortisol, cortisone and cortisol glucuronide (400 ng/ml). The 
deconjugation of the conjugated form the and the dehydrogenation in ring A 
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occurred. It was so concluded that also urine contaminated with faeces may be 
positive for prednisone and prednisolone in the same way as they are positive for 
boldenone, i.e. as a result of microbiological dehydrogenase activity on cortisol 
and cortisone (Chapter 5). The successive step was to assess the transformation 
of cortisol and cortisone in urine collected from the bladder at the 
slaughterhouse (i.e. without faecal contamination) and incubated at 37°C for 24 
hours. The influence of deconjugation with β-glucuronidase from Helix pomatia 
was assessed, too. Only urine where  prednisolone and prednisone were absent 
and cortisol was higher than 80 ng/mL were used. In this study a liquid-liquid 
extraction with a mixture of tert-Buthylmethylether:Ethylacetate (80:20) was 
performed, to concentrate the sample, so raising the sensitivity of the method. 
The analyses were carried out by LC MS3. It was demonstrated that a relatively 
high temperature (e.g. due to inappropriate storage conditions or to enzymatic 
deconjugation), could give results that do not represent the effective presence 
and concentration of the abovementioned corticosteroids at the moment of the 
sample collection (Chapter 6). However, because of the stressful conditions of 
the slaughterhouse, the by-production of prednisolone was supposed, together 
with the increase of cortisol and cortisone. The urines of three dairy cows were 
therefore collected and analyzed before and after a pharmacological induced 
stress (intra muscular administration of tetracosactide hexaacetate, an 
adrenocorticotropic hormone analogue), and before and after slaughter. 
Prednisolone was occasionally detected in the non-stressful state, but was 
consistently found in the urine of stressed cows (from 1.01 to 4.08 ng/mL), 
together with the raise in concentration of urinary cortisol and cortisone, so 
indicating a possible endogenous production of prednisolone in stressful 
situations (Chapter 7).  
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